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Abstract
Advances in the field of nanoparticle biomedical applications have made large strides
towards achieving targeted delivery of therapeutics and imaging agents. However, less is
understood on how the shape of a targeted nanoparticle will alter the level of cellular
internalization. Current research with bare mesoporous silica nanoparticles (MSNP) has
shown that a lung cancer cell’s active mechanosensory system can respond to nanoparticle
shape. The response system of the cell led to a greater non-specific macropinocytotic
internalization of rod shaped cationic MSNP with an aspect ratio of 2.1-2.5 over spherical
v

shaped cationic MSNP with an aspect ratio of 1-1.2 and larger or smaller aspect ratio rod
shaped MSNP. The research conducted herein demonstrated that by encasing the bare
MSNP with a zwitterionic supported lipid bilayer, referred to as a protocell, the aspect ratio
of the MSNP was maintained. However, the non-targeted protocell’s conformal coating
drastically diminished the ability of the cell’s active sensory system to recognize the
protocell. This finding indicates the cell envokes non-specific macropinocytosis in
response to interaction with the silanols present on the bare MSNP surface. Thus, the cell's
active shape sensory system is controlled by non-covalent electrostatic and hydrogen
bonding interactions with the biomolecular mechanosensitive components of the cell
membrane. Additionally, we establish a selective, shape enhanced internalization pathway
for the targeted rod shaped protocell AR~2.3 by conjugation of the SLB with the ligand
GE 11, which binds to EGF receptors highly over-expressed on A549 cells. Flow cytometry
involving competitive binding, chemical and 4°C inhibition on nanoparticle cell uptake,
confocal fluorescence microscopy colocalization, fluorescence plate reader and TEM
studies were performed with A549 cells. Importantly, the outcomes from these studies
showed a shift in the shape-stimulated internalization pathway from non-specific
macropinocytosis for anionic bare rod-shaped MSNP to a selective, shape-stimulated,
primarily caveolae-dependent pathway with highly preferential uptake of zwitterionic
EGFR-targeted rod shaped protocells in comparison to zwitterionic EGFR-targeted
spherical shaped protocells. The increase in average size and aggregation of the EGFRtargeted spherical MSNP EISA led to a decrease in cellular uptake compared to the EGFRtargeted spherical MSNP0.
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Chapter 1
Introduction

1

Cellular Internalization Mechanisms of Mesoporous Silica Nanoparticles
(MSNP)
Increasing interest in the use of engineered nanomaterials for applications in biology and
medicine continues to advance the current understanding of key aspects underlying the
mechanistic details involved in cellular internalization of MSNP. Extensive recent research
on engineered nanoparticles has documented that mechanisms underlying nanoparticle
internalization depend upon physiochemical characteristics such as size, shape, surface
charge, surface chemistry, surface roughness, crystallinity of the pore structure, pore size
and aggregation abilities of the nanoparticles.1 Cellular mechanistic responses including
binding, internalization and subcellular trafficking of nanoparticles change depending on
nanoparticle physiochemical characteristics as well as the cell type the nanoparticles
interact with.2-3 The natural endocytic machinery available for different types of cells due
to their respective function within the body contributes to the diverse outcomes shown in
the cellular internalization of nanoparticles. Thus it is no surprise that innate immune
mononuclear professional phagocytes such as the macrophage cells, ‘big eaters’, which are
equipped with the endocytic machinery to assist in the clearing of dead cells, various debris
and pathogens by phagocytosis also have the highest level of nanoparticle uptake. The scale
in diversity of nanoparticle cellular internalization is based on cell type with the
macrophage being the highest and the other cells such as non-dividing parenchymal cells,
having the lowest uptake.4 Even the ability of cancer cells to internalize nanoparticles can
vary drastically based on the type of cancer cell.4-9 It is therefore important to gain further
insight into the cell type specific molecular players and molecules involved in cellular
internalization of nanoparticles in vitro to be able to translate the findings and achieve
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targeted delivery of therapeutics and imaging agents to the desired location within the
body.
There are many common methods employed to study in vitro mechanisms of cellular
internalization of nanoparticles in combination with cell culture. Flow cytometry is one
method used to study the amount of nanoparticle uptake by cells, in combination with
chemical, temperature or gene silencing inhibition to discriminate among the cellular
endocytic pathways are involved in nanoparticle uptake. Competitive inhibition studies to
determine specificity of the targeting moiety on the nanoparticle. A second technique to
investigate cellular binding, internalization, trafficking and interaction of nanoparticles
with cellular biomolecules is differential interference contrast microscopy and confocal
fluorescence microscopy in combination with immunohistochemistry. Nanoparticle
binding kinetics, level of internalization, fluorescence calibration curves for dye loading
and cell viability can be determined using plate reading methods. Transmission electron
microscopy (TEM) is used to investigate nanoparticle shape, size, size dispersity, pore size
and determine nanoparticle cell interaction and cellular internalization pathways. Small
powder X-ray diffraction is employed to determine nanoparticle pore symmetry. The
assessment of nanoparticle surface area and pore size is achieved by analysis of nitrogen
absorption/desorption isotherms. The hydrodynamic nanoparticle size is found by using
the dynamic light scattering technique. The zeta potential of the nanoparticle can be taken
to measure the nanoparticle charge. The transmission scanning electron microscopy
(TSEM) technique is used to assess nanoparticle shape, size and size dispersity. Atomic
force microscopy (AFM) is used to study the nanoparticle size, morphology, surface
texture, surface roughness, surface area, and volume distributions. Energy dispersive
3

spectroscopy (EDS) technique allows for the quantification of elemental analysis of
nanoparticles in cells. The western blot method is used to determine specific proteins
associated with nanoparticle interaction with cells. The electron energy loss spectroscopy
(EELS) technique allows for elemental analysis of nanoparticles in cells. Image cross
correlation spectroscopy (ICCS) is used to determine the number of nanoparticles per unit
area.
Natural endocytic mechanisms such as phagocytosis, macropinocytosis, clathrindependent and caveolin dependent have been investigated as internalization pathways for
nanoparticles often showing multiple internalization pathways for the same
nanoparticles.11-16 A brief classification of cellular mechanisms of internalization will be
presented in order to provide a better understanding of the cellular mechanisms involved
in mesoporous silica nanoparticle internalization. Current research findings on the effect
changes in physiochemical characterizations such as shape, size and surface chemistry
have on cellular endocytosis, trafficking and exocytosis of mesoporous silica nanoparticles
and other nanoparticles will be discussed. A brief review of the thermodynamics of
nanoparticle cellular endocytosis with differences based on the geometry of the
nanoparticle. The following section provides a comprehensive background on the
landscape of cellular mechanisms of MSNP and nanoparticle internalization with
conceptualization on how to allow for successful utilization of these nanocarrier systems
for the delivery of therapies and imaging agents.
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Natural Mechanisms of Cellular Endocytosis
The cellular mechanisms of nanoparticle internalization rely on cellular pathways inherent
to the cells for uptake of nutrients, receptors, fluids, pathogens and factors associated with
cell function regulation. Common routes of inherent cellular internalization depicted in
Figure 1, include phagocytosis, macropinocytosis, as well as clathrin-dependent, caveolinmediated, clathrin and caveolin-independent processes.

Figure 1: Natural Mechanisms of Cellular Internalization.
Macropinocytosis and phagocytosis are two routes of cellular internalization requiring
actin involvement for uptake of large gulps of extra cellular fluid and large particles,
respectively. Cellular internalization of smaller particles is traditionally thought to be
clathrin-dependent and/or caveolin-dependent with recent research indicating other cellular
internalization pathways that are clathrin and caveolin independent which as depicted can
involve dynamin independent carriers (CLICs) that traffic the cargo to glycosyl
phosphatidylinositol-anchored protein enriched early endosomal compartments (GEEC)
before combining with the early endosome. Reprinted with permission from Nature
Publishing Group reference 6.6 Copyrighted 2007 Nature Reviews Molecular Biology.
These natural mechanisms of cellular internalization are often categorized according to the
size of particle or volume of fluid being taken up into the cell. Phagocytosis and
5

macropinocytosis are most noted for taking up larger particles and volumes of fluid
respectively, while the routes of clathrin and caveolin dependent or independent pathways
are traditionally considered for uptake of smaller volume of particles and fluid.6,17-19
Phagocytosis and Macropinocytosis
Phagocytosis and macropinocytosis are similar energy dependent routes of cargo uptake in
that both endocytic processes involve actin cytoskeleton recruitment to facilitate endocytic
cup formation and the formation of larger size vesicles, as depicted in Figure 1. Although
they both form larger size vesicles, macropinocytosis often results in large amount of fluid
in the macropinosome as compared to the phagosome that is formed during phagocytosis
which has much less fluid and takes on the shape of the cargo being ingested.6,

20

Phagocytosis serves as one of the primary endocytic routes for pathogens including
bacteria (e.g. Mycobacterium tuberculosis) and viruses (e.g. HIV and herpes virus).18, 21-24
The phagocytic process is not only significant for pathogen entry into cells, but also further
evidence suggest that the phagocytosis of larger particles such as apoptotic and necrotic
cells assists in the proper function and development of the immune system.20, 24-25
Macropinocytosis is an endocytic pathway, which cells utilize to engulf solute
macromolecules or large volumes of extracellular fluid. It involves cell membrane ruffling
and is considered one of the oldest eukaryotic endocytic pathways.25-28 The extracellular
fluid taken up by the macropinocytotic route carries cellular components involved in cell
communication and motility including growth factors, antigen stimulating factors and cell
nutrients, as well as, infectious pathogens such as bacteria or viruses that hijack the
pathway to gain entry into cells.20, 24
6

Mechanisms of phagocytosis involved in the entry of bacteria invading host cells has been
reported to occur by either the activation of receptors on the plasma membrane of the host
cell eliciting the “zipper” mechanism or by the release of proteins from the bacteria into
the cytosol of the host cell leading to the “trigger” mechanism which both involve actin
rearrangement.28, 29-30 Once the newly formed phagosome is released from the plasma
membrane it is thought to be shuttled to the lysosome through a process which involves
small GTPases, Rab5 and Rab7, and microtubules that assist in phagosome maturation and
fusion of the phagosome to the early and late endosomes/lysosomes (endolysosomal
compartments), respectively, where the cargo is acidified and degraded or in some cases to
lamellar bodies that facilitate their subsequent exocytosis and release of cargo to the
extracellular milieu.20, 25, 30-32
In macropinocytosis the non-selective engulfment of extracellular components occurs by a
Rac1 GTPase dependent actin driven energy requiring process involving PAK1, PI3K, Ras,
Src and HDAC proteins. These proteins elicit plasma membrane filopodia protrusions,
ruffling and blebbing involving actin rearrangement. The filopodia protrusions capture
large amounts of the extracellular milieu as they fuse back with the basal membrane
forming a macropinocytic cup.20, 24, 33 After the fission of the macropinocytic cup at the
plasma membrane is complete, a vesicle termed a macropinosome is formed.34-36 The
macropinosome goes through a maturation process after which it is either trafficked by
microtubules to the late endosome/lysosome for degradation or sent for recycling to the
plasma membrane.18, 20, 24, 33, 36

7

Clathrin and Caveolin Dependent Cellular Internalization
Clathrin dependent endocytosis has been the most extensively studied pathway to date. The
pathway involves a trimer of heterodimers, with each heterodimer containing one heavy
and one light chain to create a triskelion37 These trimer of heterodimers form a lattice like
structure around the vesicles containing the cargo.38-39 This cell type specific dependent
process starts by binding of trans-membrane receptors by their cognate ligands or cargo
leading to clathrin polymerization with membrane bending assisted by BAR (Bin
Amphiphysin Rvs) domain containing proteins, like amphiphysin and endophilin.20, 24, 40-41
Once the mature clathrin coated vesicle is formed it is released by a scission process
involving dynamin GTPase. The clathrin coated pit vesicle with cargo in tow subsequently
loses the clathrin coat before merging with the early endosome; where the cargo is sorted
to either get recycled to the plasma membrane or sent to the late endosome/lysosome for
degradation. 20, 24, 40-41
Caveolar-dependent endocytosis serves as another route for cellular uptake of extracellular
cargo. The main component of caveola are caveolins. Caveolins are integral membrane
proteins that contain a hairpin domain located within the membrane.24 There are three
known mammalian caveolins, caveolin 1 (CAV1), caveolin 2 (CAV2) and caveolin 3
(CAV3). The main caveolin in non-muscle cells is caveolin 1, thus caveolin 1 (CAV1)
mediated endocytosis serves as the focus for this caveolar discussion.24 CAV1 is a
cholesterol and fatty acid binding protein. The involvement of CAV1 during the start of
caveola invagination at the plasma membrane helps ensure proper structure and function
of the caveola.42 Caveolin 1 forms oligomers with membrane domains rich in cholesterol
at the start of caveola formation. The CAV1 oligomers and cholesterol-rich membrane
8

domains then attract cavins, cytoplasmic coat proteins, which assist in the stabilization of
the newly forming caveola.42-43 The intact cellular cortical actin network helps to keep the
maturing caveola at the cell membrane and the release of the caveola from the plasma
membrane requires reorganization of the actin cytoskeleton. Release of the mature caveola
also requires scission protein, large GTPase, dynamin II, which allows scission of the
mature caveola at the neck of the invagination from the plasma membrane in a process
regulated by Src kinases (tyrosine kinases) and protein kinase C.43-44 The cellular
microtubules step in to assist in shuttling the newly released caveola away from the plasma
membrane.44 After budding from the plasma membrane the caveola fuses with either a
caveosome by a Rab5-independent process or to an early endosome in a Rab5-dependent
process.43 The fusion of the caveola with caveosome and early endosome is thought to be
bidirectional.44 Once to the caveosome the caveola cargo is then trafficked to the multivesicular bodies, where it is believed to be able to escape a degradative fate.16, 44 Fusion of
the caveola to early endosomes can lead to further trafficking to the recycling endosome or
late endosomes and lysosomes for degradation.44
Clathrin and Caveolin Independent Endocytosis
The clathrin-independent pathways of cellular internalization involve multiple mechanisms
including dynamin-dependent and dynamin-independent pathways.18 Examples of
dynamin-dependent pathways include the RhoA dependent and GRAF1 (GTPase regulator
associated with focal adhesion kinase-1) regulated endocytic mechanisms. The formation
of tubulovesicular clathrin-independent carriers (CLICs), depicted in Figure 1, is a process
involving GRAF1 mediated restructuring of the membranes which is significant in cargo
uptake. The CLICs are further trafficked to glycosyl phosphatidylinositol-anchored protein
9

enriched early endosomal compartments (GEEC) to be trafficked to the late endosome
followed by subsequent delivery to the lysosome for degradation.6, 24 Recycling of the
cargo in CLICs back to the plasma membrane uses mechanisms relying on lipid domains
and proteins.42 Recycling of the cargo before fusion with the early endosome has been
noted to involve the Rab GTPases proteins, Rab8, Rab22 and Rab 35.46-47 The dynamin
independent mechanisms of cellular uptake of cargo on the other hand are currently known
to involve Cdc42 or Arf6 (adenosine diphosphate-ribosylation factor 6) and flotillin
molecular players to achieve cellular internalization to the endosomal and lysosomal
compartments of the cell for further degradation.18, 48-50 Less research has been carried out
to investigate MSNP internalization by the clathrin- and caveolar-independent pathways;
therefore, the focus of this section will be on phagocytosis, macropinocytosis, clathrin- or
caveolin-dependent endocytosis.
Shape, Surface Chemistry and Size Effects on Cellular Internalization of
Nanoparticles
The main physiochemical aspects of mesoporous silica nanoparticles (MSNP) currently
being investigated as determinants of the nanoparticle internalization pathway and
efficiency are size, shape, pore morphology, and surface chemistry, e.g. charge, hydroxyl
coverage, extent of PEGylation, and conjugation of targeting and internalization ligands.11,
51-57

Altering the size, shape and surface chemistry of mesoporous silica nanoparticles has

been demonstrated to change the cellular uptake mechanism in multiple cell lines in a cellspecific manner and will comprise the following discussion.2, 3, 5-7
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Shape, Surface Chemistry and Size Effects on Cellular Phagocytosis and
Macropinocytosis of Nanoparticles
Shape is one of several parameters of MSNP that alter the possibility of phagocytic cellular
internalization.57 A study investigating the role of geometry on cellular internalization of
spherical (TEM size ~178 nm; ζ = +58 mV), cylindrical (TEM size ~ 214 nm by 428 nm;
ζ = +79 mV) and worm (TEM size ~ 232 nm by 1348 nm; ζ = +87 mV) shaped MSNP
demonstrated using flow cytometry that worm shaped MSNP were in part phagocytosed
by macrophages and epithelial cells.57 The phagocytosis of the worm MSNP but not the
spherical MSNP was suggested to be due to the orientation of the nanoparticles and their
curvature upon approach at the surface of the plasma membrane of the cells.57 Phagocytosis
of MSNP and nanoparticles has been indicated to rely on the free energy at the surface of
the plasma membrane of the cell.55 It has been reported that a negative zeta potential value
of the interfacial free energy of nanoparticles can be linked to an increase in nanoparticle
phagocytosis.55 An additional factor related to a rise in phagocytosis of nanoparticles is
hydrophobicity of the nanoparticle.54 An increase in hydrophobicity of the nanoparticle
leads to greater levels of phagocytosis as was shown in research with polymer microspheres
that had diameters between 1 and 10 µm internalized to a greater degree in macrophages.58
In a study investigating the A549, type II alveolar epithelial cell internalization of Ti02
(titanium dioxide) it was demonstrated by TEM, electron spectroscopic microscopy,
energy filtered TEM, and electron energy loss spectroscopy that phagocytosis occurs with
larger size nanoparticles.14 In this study the nanoparticles with a diameter of 50 nm were
not readily internalized unless they were aggregated. The aggregation resulted in a larger
size, which was shown to be taken up by a phagocytic process.14 Once internalized the
11

Ti02 particles were located in membrane bound vacuoles and within lamellar bodies.14 In
other research using flow cytometry, confocal fluorescence microscopy, TEM, image cross
correlation spectroscopy, to investigate A549 cellular internalization and intracellular
trafficking of spherical lipid coated gold nanoparticles (diameter of 20-30 nm and a zeta
potential of – 65 mV) it was again found that the nanoparticles were trafficked to the
lamellar bodies.32 However, in this study they observed the intracellular trafficking of the
lipid coated gold nanoparticles post 72 hours and found a drop in the level of gold
nanoparticles in the cells suggesting that the nanoparticles were slowly exocytosed from
the cells.32 In addition, it is known that Type II alveolar epithelial cells, A549 cells, use
lamellar bodies as a means to transport lung surfactant to the plasma membrane with
subsequent exocytosis to the alveolar fluid to participate in constructing the surfactant
monolayer structure.32, 59 It is plausible to consider if MSNP were functionalized to allow
for ingestion into cells via phagocytosis they could be exocytosed out of the cells.
However, as mentioned earlier in the mechanistic details of phagocytosis it is still possible
for pathogens and therefore probable for nanoparticles to be phagocytosed into cells and
trafficked to the endolysosomal pathway. Importantly, a clinically relevant consideration
for biofunctionalization of MSNP surface chemistry to allow for trafficking to the
endolysosomal pathway via phagocytosis would be to achieve targeted enzymatic release
of therapeutics for the treatment of lysosomal storage diseases.60
Macropinocytosis has been demonstrated to be a cellular internalization pathway utilized
by cells for non-selective uptake of non aggregated MSNP and other nanoparticles.8, 15, 61
Research utilizing flow cytometry and confocal microscopy was performed to determine if
MSNP size impacts the magnitude of cellular uptake and endosomal escape in MC3T3-E1
12

pre-osteoblast cells. The study found that MSNP (55~440 nm with a negative charge, -34.7
mV) were all endocytosed with subsequent escape from the endosomes. The research also
showed the magnitude of cellular internalization and endosomal escape of the MSNP
depended on the particle size and the best levels were found with the 100 nm MSNP.62
However, these findings are in contrast to other research performed with MSNP ranging in
size from 30-280 nm.53 In this research using flow cytometry and confocal fluorescence
microscopy a decrease in cellular uptake of the particles above or below 50 nm, all with a
neutral charge at pH 7, was shown in HeLa cancer cells (Figure 2).53 These differences
between cell type internalization responses to MSNP based on their size and charge
highlights the need to investigate the MSNP parameter of size and charge within the cell
type of interest.
In other research the influence of nanoparticle shape on cellular internalization into A375
human melanoma cells was investigated using TEM and confocal fluorescence
microscopy.51 The study used three different shaped monodispersed mesoporous silica
nanoparticles with the following aspect ratios: spherical (aspect ratio (AR) of 1, diameter
of 100 nm ± 15 nm), medium rod (AR of 2, length 240 nm ± 18 nm), and large rod (AR of
4, length 450 nm ± 11 nm), with the same particle diameter, negative surface charge and
chemical makeup. All of the MSNP were found to be internalized by a non-specific route,
further trafficked to the early endosome and localized in the cytosol.51 The study found the
large rod with an aspect ratio of 4 was taken up to the greatest degree over the other two
shaped particles indicating that the A375 cellular machinery is able to recognize and
respond to a difference in the geometry of the MSNP.51 An additional research study was
conducted to determine the role of MSNP shape/aspect ratio on HeLa and A549 cellular
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internalization. In this study the effect of MSNP aspect ratio (AR) on cellular
internalization was studied using flow cytometry, confocal fluorescence microscopy,
western blot and TEM of cell monolayers. The results indicated that the positively charged
bare FBS coated intermediary size rod MSNP2 (dimensions 160-190 nm/60-90 nm, AR
~2.1-2.5) led to the greatest level of cellular uptake, small GTP binding protein, Rac1 and
CDC42 activation and polymerization in comparison to the other shaped MSNP: spherical
(AR~ 1-1.2, diameter of 110 nm), small rod (110-130 nm/60-80 nm, AR ~1.5-1.7) and
large rod (260-300 nm/50-70 nm, AR~4-4.5).15 The 4°C and amiloride chemical inhibition
flow cytometry study and TEM of cell monolayers using cells incubated with MSNP2
demonstrated that the intermediary rod MSNP2 were taken up by an energy dependent
macropinocytosis route.15 Interestingly, differences of the large rod MSNP, AR~4, having
greater cellular uptake in A375 cells versus the medium rod MSNP, AR~2.1-2.5, having a
greater cellular uptake in HeLa and A549 cells indicate that the shape or geometry of the
MNSP and overall charge of the MSNP influences cellular uptake in a cell type specific
manner.15, 51 Changes in cellular uptake based on cell type has also been demonstrated in
other nanoparticle research.4
The ability of cells to detect and respond to changes in the aspect ratio of MSNP,
shape/geometry is an important parameter to harness in using MSNP as a drug/imaging
delivery platform. The ultimate fate of a macropinosome for degradation of cargo in the
lysosome or recycling of contents to the extracellular milieu and non-specific uptake of
bare MSNP into disease as well as healthy cells is not conducive to creating an efficacious
nanocarrier for drug or imaging delivery.56 To overcome these issues modification of the
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surface chemistry of the MSNP to allow for a directed selective cellular uptake of the
MSNP into diseased but not healthy cells has been conducted.11, 56

Figure 2: Cellular uptake studies of different sized FITC labeled MSNP in HeLa cells.
The qualitative confocal spectral microscopy study was performed with HeLa cells
incubated with a 100 µg/mL of FITC labeled MSNP for 5 h at 37 °C. The MSNP sizes in
each image were: (A) 170 nm (B) 110 nm (C) 50 nm and (D) 30 nm. The stains were as
follows: F-actin (cytoskeleton) - rhodamine phalloidin (red); cell nucleus - 4’, 6-diamidino2-phenylindole (DAPI) (blue); MSNP – FITC (green). (E) Inductively coupled plasma
mass spectrometry (ICP-MS) was performed separately from the confocal spectral
microscopy study with the different size MSNP incubated with HeLa cells for 5 hours at
37 °C. The ICP-MS findings of the amount of mass in pg of cellular uptake versus the size
of the FITC labeled MSNP. Reprinted and modified with permission from John Wiley and
Sons reference 53.53 Copyrighted 2009 by Wiley Press.
Shape, Surface Chemistry and Size Effects on Clathrin and Caveolin Dependent
Endocytosis of Nanoparticles
Altering the physiochemical characteristics of nanoparticles shape, surface chemistry and
size has been utilized to direct nanoparticles to diseased over healthy cells by shifting
cellular internalization from non-specific to targeted clathrin-dependent and/or caveolindependent endocytosis. 11, 13, 15, 53, 54, 56, 60, 63, 67 Present techniques for addressing the nonspecific uptake of nanoparticles has been to decrease the rate of non-specific uptake by
neutralizing the nanoparticle surface charge or making the surface more hydrophilic. To
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achieve this multiple strategies have been employed. One method to neutralize the surface
of nanoparticles has been to add a polymeric coating like polyethylene glycol, PEG, to the
nanoparticle surface. 55 The addition of PEG to the nanoparticle surface assists in reducing
protein adsorption by creating a steric brush decreasing the interaction with the plasma
membrane; however, it has been indicated to be a transient effect.17 Another method used
to decrease non-specific cellular internalization of nanoparticles is by the fusion of a
supported lipid bilayer to the surface of the MSNP.11 The modification of MNSP and other
nanoparticles with targeting moieties such as peptides, antibodies, oligonucleotides and
aptamers that bind receptors highly overexpressed on cancer cells has been demonstrated
to be very successful.11, 13, 17, 53, 56, 60, 67 The targeting of the MSNP can lead to different
mechanisms of cellular internalization of the nanoparticle.13,17,54 Understanding the
pathway of cellular endocytosis taken by the targeted nanoparticle assists in determining
the subcellular fate once internalized by the cells. If nanoparticles are taken up by the cells
via a clathrin-dependent process they are trafficked to the lysosomal compartment.

54

However, if the nanoparticles are internalized by a caveolin-dependent process they are not
destined for degradation in the lysozymes.17 Therefore, if a targeted nanoparticle is
internalized by the cell in a clathrin-dependent process escape from the endosome needs to
happen before fusion with the degradative lysosomes to ensure intact cargo. The endosomal
escape of the nanoparticle cargo is important for delivery to the specified cellular
organelle/compartment, nucleus, mitochondria or cytosol.12,

17, 18, 54

Polyethyleneimine

(PEI) polymers and cell penetrating peptides also used to modify the surface of MSNP to
enhance cellular uptake, allow for direct cell delivery and endosomal escape once inside
the cell.54
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Recent research studied the ability to target MSNP to hepatocellular carcinoma cells over
healthy human hepatocytes. To achieve this MSNP were fused with a supported lipid
bilayer and conjugated with a SP94 targeting peptide, a hepatocellular carcinoma peptide
with greater affinity to Hep3B cells versus human hepatocytes. The findings showed a
reduction in non-specific cellular uptake of bare MSNP in healthy human hepatocytes and
human hepatocellular carcinoma Hep3B cells. The addition of the targeting peptide, SP94,
was found to lead to a selective cellular internalization into Hep3B cells over human
hepatocytes, endothelial cells or immune cells.56 The study outcomes showed a significant
increase in the efficacy of the therapeutics delivered to Hep3B cells and hepatocytes
compared to the free drug and liposomal delivered drug.
This study also indicated that the biofunctionalized MSNP termed the ‘Protocell’ was
trafficked to the early endosome where the additional endosomal lytic peptide
functionalized to the supported lipid bilayer allowed for the release of the protocell into the
cytosol where the cargo was released.56 The release of cargo modified with a nuclear
localization sequence from the protocell was demonstrated to achieve targeted delivery of
calcein and the dsDNA oligonucleotide to the nucleus.56 This research highlights the
capability to shift nanoparticle uptake to be selective by the surface functionalization of
MSNP with a supported lipid bilayer; however, further studies to unravel the mechanistic
details of the endocytic machinery involved in the selective uptake of the MSNP will be
needed. It is plausible that this shift from non-specific macropinocytosis to a selective
receptor-mediated mechanism of cellular internalization involved clathrin- or caveolindependent endocytosis. The details on mechanisms of cellular internalization of targeted
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MSNP is a burgeoning area of MSNP research; therefore, further discussion will also
include other types of nanoparticles.
Clathrin-dependent endocytosis has been implicated in the cellular internalization
mechanism of several pathogens and nanoparticles. The pathogens known to involve
clathrin mediated endocytosis include viruses, such as Adenovirus, SARS coronavirus and
Ebola virus, and bacteria, such as bacterium, L. monocytogenes.64-66 An example of
clathrin-dependent endocytosis of nanoparticles from previous research discussed next
supports this pathway as a cellular mechanism used by cells to internalize nanoparticles.
Research conducted to examine the influence of surface modification of MSNP on cellular
uptake in HeLa cells indicated clathrin-dependent endocytosis for some of the
nanoparticles. The study involved MSNP with the following surface charges and
modifications: highly negatively charged (ζ = -34.73 mV) FITC labeled MSNP (FITC
MSNP); less negatively charged MSNP functionalized with 3-aminopropyl (AP) (ζ = -4.68
mV) (MSNP AP); guanidinopropyl (GP) (ζ = -3.25 mV) (MSNP GP) and positively
charged (ζ = +12.81 mV) FITC labeled MSNP functionalized with folate groups (FAP
MSNP). Interestingly, confocal micrograph colocalization studies of HeLa cells incubated
with the FAP MSNP and FITC MSNP showed that both positively charged FAP MSNP
and highly negatively charged FITC MSNP were internalized and retained in the
endosomes; on the other hand the AP MSNP and GP MSNP readily escaped the endosomes
by 6 hours.67 This suggests that the AP MSNP and GP MSNP enter into the HeLa cells by
a different endocytotic process than the FAP MSNP and FITC MSNP. The inhibition
studies performed in this research supported the change in endocytosis pathway for the
internalization of the different MSNP. The flow cytometry for FAP MSNP and FITC
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MSNP upon inhibition of clathrin coated pits with 450 mM sucrose indicated that clathrin
dependent internalization was involved by a decrease in their cellular uptake, which was
not seen with the AP MSNP or GP MSNP.67 However, when the different MSNP were
treated with the chemical caveolar inhibitor, genistein, only the AP MSNP and GP MSNP
showed a decrease in cell uptake determined using flow cytometry. Further the FAP MSNP
were shown by flow cytometry to be inhibited by 1 mM folic acid whereas the FITC MSNP
were not inhibited indicating that FAP MSNP endocytosis in HeLa cells was governed by
targeting of the folate acid receptors on HeLa cells.67 It is plausible that shuttling of the AP
MSNP and GP MSNP out of the endosomes could have also led to their trafficking to the
caveosomes as it was noted earlier that caveolar-dependent internalization allows for cargo
to be trafficked from early endosomes to the caveosomes.44
In fact, one of the unique features of caveolin-mediated endocytosis is the ability of the
nanoparticles to be directed to a pH neutral caveosome allowing for release of the cargo
into a non-degradative environment without the addition of an endosomal lytic peptide.44,
68

The caveolar route of internalization has been indicated in research probing the cellular

uptake mechanisms of negatively charged 17 nm silica-coated iron oxide nanoparticles
(SCIONs) and negatively charged PEGylated superparamagnetic iron oxide nanoparticles
(SPIONS) in HeLa cells.69-70 In this research it was found by flow cytometry that the
knockdown of caveolin 1 by siRNA led to a large decrease in the cellular uptake of both
of the nanoparticles in HeLa cells. These findings indicated that caveolar dependent
endocytosis of the nanoparticles was the main route of internalization.69-70 Interestingly,
another study investigated the role of size in the cellular internalization of fluorescent latex
beads in non-phagocytic B16, murine melanoma cells.16 The study used fluorescent latex
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beads with a range of sizes from 50 nm to 1000 nm (charge not reported). The flow
cytometry experiment performed with cholesterol depletion using the inhibitor, methyl-βcyclodextrin and incubation at 4°C indicated that beads larger than 200 nm were
endocytosed in non-phagocytic B16 cells and murine melanoma cells, principally by an
energy dependent caveolar internalization pathway.16 The confocal scanning microscopy
colocalization studies supported the flow cytometry findings by showing colocalization of
the beads larger than 200 nm with an antibody for caveolin 1. However, latex beads under
the size of 200 nm were found by flow cytometry to have a decrease in cellular uptake
upon inhibition of clathrin with depletion of intracellular potassium and chloropromazine
indicating clathrin-dependent endocytosis. The latex beads under 200 nm were also shown
by confocal microscopy to have a decrease in cellular uptake when an Eps 15 mutant
required for clathrin-mediated endocytosis was expressed in cells. The findings supported
the idea that the size of the fluorescent beads without ligands led to differences in their
cellular route of internalization.16 This study demonstrates that when nanoparticles are not
further functionalized with targeting moieties or coatings, size can lead to differences in
the endocytic process used by the cell for internalization.16
A study supporting caveolar-dependent endocytosis of nanoparticles was carried out to
investigate the effects of surface chemistry functionalization of lipid nanoparticles with
sulfonate containing polymers and other polyelectrolytes on the route of cellular
internalization in HeLa, cancerous epithelial cells, and HUVEC, endothelial cells. The
confocal fluorescence microscopy findings from the study indicated positive colocalization
of the nanoparticles with caveolin 1 supporting a caveolar pathway of endocytosis of the
nanoparticles. In addition caveolar endocytosis of the nanoparticles was supported by a
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flow cytometry study that showed a decrease in the nanoparticle cellular uptake upon
inhibition with Filipin-III, a chemical inhibitor that binds cholesterol and disrupts caveolae
uptake.68
Interestingly, the outcomes with the lipid nanoparticles which were negatively charged and
were 180 nm in size indicate that caveolin dependent endocytosis of nanoparticles is not
merely reliant on the size of the nanoparticles but also relies on the charge and lipophilicity
of the nanoparticles.

16

These findings contrast the research previously mentioned where

clathrin dependent endocytosis was shown to be the primary route of internalization of
fluorescent latex beads which were under the size of 200 nm.

68

The differences in

outcomes of these two studies demonstrate that surface chemistry is also an important
factor that effects the cellular uptake of nanoparticles. It is important to note that the
differences between cell types could also lead to a difference in the changes in endocytic
routes taken for nanoparticles with varying sizes and surface chemistries.1
The findings from these studies give credence to the size restriction on budded caveolae
from the plasma membrane of cells not being solely restricted to the traditional size of 80
nm when they are involved in nanoparticle cellular endocytosis. The outcomes from these
studies also strongly suggest the lipophilicity as well as to some degree the charge of the
nanoparticle plays a role in eliciting caveolar dependent cellular internalization.6, 16, 68,69
On the other hand, a study exploring human umbilical vein endothelial cells (HUVEC),
cancerous epithelial cells (HeLa), human embryonic kidney cells (HEK 293) and primary
mouse bone marrow dendritic cells (BMDCs) internalization of anionic polyethylene
glycol diacrylate (PEGDA)-based hydrogel nanoparticles with different geometry found
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varying cell type specific mechanisms of internalization of nanoparticles based on their
shape and size.8 Specifically, the results showed that the BMDCs and Hela cells
internalized nanodiscs to a higher level than nanorods with the increasing size of the
nanoparticles leading to greater amounts of internalization. In contrast the HUVEC cells
preferentially internalized intermediary sized discs (220 nm) versus discs of larger and
smaller volumes and nanorods.8 While HeLa, HEK 293 and HUVEC cells used
macropinocytosis in part to take up the nanoparticles, it was determined that the HUVEC
cells favored the faster clathrin dependent pathway of internalization leading to higher
levels of nanoparticle internalization. In contrast, the epithelial HeLa cells internalized the
nanoparticles via a caveolae directed pathway.8 This research suggests that cellular
mechanisms of internalization of nanoparticles are influenced by the size and shape of the
nanoparticles as well as by the amount of interaction of the nanoparticle at the surface of
the cell plasma membrane, degree of adhesion between the nano-bio interface and the
required strain energy for membrane wrapping.8
The function of shape and size of nanoparticles combined with the rigidity and tension of
the membrane during bending has become of interest in understanding nanoparticle cellular
internalization. To better grasp the impact of these factors on nanoparticle cellular uptake
recent research studies were conducted to gain further insight into the physical energy
requirements necessary for particle penetration across a lipid bilayer, particle membrane
wrapping and particle internalization.71-72 Outcomes from these studies which highlight
receptor mediated endocytosis of nanoparticles (clathrin and clathrin independent
endocytosis) indicate that essential aspects for interaction of a nanoparticle with the lipid
bilayer involves the nanoparticle shape anisotropy, volume, and initial relative physical
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position to the lipid bilayer. The studies revealed that the nanoparticle contact area with the
cell lipid bilayer and local curvature of the nanoparticle interface with the cell lipid bilayer
contributes to nanoparticle penetration.71-72
It was determined that at the highest nanoparticle contact area with the lipid bilayer that
nanoparticle penetration is lowest.72 The directional approach of the anisotropically shaped
nanoparticle at the lipid bilayer that gives the least amount of initial contact area and has a
disruption area that slowly decreases or stays constant while transiting the lipid bilayer has
a lower required penetration force. Thus, an anisotropic rod shaped nanoparticle with a
uniform diameter interacting with the lipid bilayer at the tip where the length of the rod
shaped nanoparticle is perpendicular to the cell membrane gives a smaller disruption area
imparted on the lipid bilayer of the cell. Since the diameter of the anisotropic rod shaped
nanoparticle does not increase as the rod particle is internalized the required energetics for
penetration remain low. On the other hand, if the nanoparticle disruption area in the lipid
bilayer rises the force requirement for penetration will increase. The energy requirements
for penetration will decrease as the particle height becomes larger.72 For example if you
have half of an ellipsoid particle that makes contact with the cell membrane at the tip end
first then the disruption area of the lipid bilayer will increase as it transits through the lipid
bilayer. Therefore, the necessary energy for penetration of the lipid bilayer for the half
ellipsoid particle will increase with the incremental increases in penetration force becoming
less with larger particle height. Anisotropy in this and the following context refers to the
contact area of the local curvature of the nanoparticle and the nanoparticles respective
direction upon first interaction with the lipid bilayer. The effect of particle volume on lipid
bilayer penetration for nanoparticles with varying shape anisotropy was found to be
23

independent of nanoparticle volume. It was also found to be possibly less difficult with
increasing nanoparticle volume.
The effect of particle volume with anisotropic nanoparticles is in contrast to the findings
with isotropic spherical nanoparticles where increasing volume leads to an escalation in
the energy requirements for penetration and translocation through the lipid bilayer.72 In
addition to the shape of the nanoparticle, the nanoparticle surface chemistry plays a role in
penetration energy requirements where an increase in the level of hydrophobicity of the
nanoparticle surface leads to a drop in the energy required.72
An additional study was conducted to look into the endocytosis kinetics of ligand-coated
nanoparticles with varying geometries.73 This study found that an important mechanism
for endocytosis of anisotropic nanoparticles involves the rotation of the nanoparticles
which controls the balance between ligand-receptor binding and membrane deformation.
It is suggested that the geometry of the nanoparticle leads to a two stage endocytic process
involving membrane invagination and nanoparticle wrapping. The membrane invagination
stage is dominated by the strong ligand-receptor binding energy which causes rotation of
the nanoparticle in such a manner as to allow for the maximum contact area with the plasma
membrane.73
The second stage of the endocytosis process comprises the wrapping stage and is most
impacted by the biggest local mean curvature of the nanoparticle which causes the
membrane to be at the highest level of bending and sensitive to the membrane tension. The
wrapping and internalization of the nanoparticle leads to negative driving forces related to
the deformation of the cell membrane and the rearrangement of the cytoskeleton to allow
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for the cell to adapt to the surface of the nanoparticle as well as the recruitment of receptors
at the contact area by membrane diffusion allowing for new receptors for binding.74 The
nanoparticle internalization thus changes with respect to the favorable orientations during
the two stages based on the shape anisotropy with one or two different orientation
readjustments possible in the endocytosis process.73 The exact details of the energy
requirements for nanoparticle endocytosis with respect to the differential use of endocytic
machinery such as clathrin and caveolin still remain to be clearly delineated.
Despite major strides in the advent of new classes of nanocarriers able to deliver combined
therapeutics and diagnostics (i.e. theranostics) or incorporate appropriate environmentally
triggered gating and release strategies, there continues to be a limited grasp of nanoparticle
internalization mechanisms and their reliance on physiochemical properties in regards to
size, shape, and surface chemical properties. This deficiency can be attributed to the
challenges in independently altering these physicochemical properties for a particular
nanocarrier class. Most of the recent studies have focused on probing the different
internalization mechanisms involved in the cellular uptake of naturally occurring viruses,
bacteria, growth factors, and other biomolecular components rather than nanoparticles. 1,
17-24, 29, 31

The variation in rates and efficiencies of cellular mechanisms of internalization

dictated by particular intracellular trafficking pathways have the ability to alter the amount
of cargo delivered into a cell and subsequently the subcellular fate of cargo in tow. Thus,
understanding how to manipulate the route of cellular internalization for a nanocarrier is
of paramount importance in increasing the efficacy of nanoparticle-based therapeutics and
imaging agents. 18-19
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The overarching goal of this dissertation research was to elucidate the influence that MSNP
aspect ratio, shape, and surface chemistry have on their potential to be identified and
internalized by the cell’s active sensory system. Prior studies performed in our laboratory
showed that the fusion of a conformal zwitterionic 4-nm thick supported lipid bilayer
(SLB) on an MSNP allowed for preservation of its size. We hypothesize that the addition
of this conformal SLB coating on the MSNP with different shapes will maintain the shape
and size of the MSNP. The MSNP surface silanols Si-OH and deprotonated silanols SiO- can interact with cell membranes via hydrogen bonding and electrostatic interactions,
respectively, leading to an increase in the uncoated MSNP cellular uptake. 11, 56 We also
hypothesize that the addition of the SLB to the MSNP with different shapes will strongly
reduce the capacity for the identification of the nanoparticles by the cell’s active sensory
system. We believe the blanketing of the MSNP surface silanols Si-OH and deprotonated
silanols Si-O- with an SLB coating allows for the reduction in the cell’s ability to identify
the MSNP. We determined that adding the SLB preserved the MSNP aspect ratio while
also diminishing the non-specific, shape-stimulated macropinocytotic pathway for A549,
non-small cell lung (NSCLC) cells, and MRC9, healthy lung fibroblast cells. This finding
demonstrates that the non-covalent electrostatic and hydrogen bonding interactions
between the silanols (and amines) on the surface of the MSNP with the biomolecular
constituents of the cell membrane regulate MSNP recognition by the cell sensory system.
The other goal of this dissertation research was to elucidate whether it would it be possible
to alter the surface chemistry of the MSNP to create a specific shape-induced
internalization pathway for uptake into cancerous lung A549 cells with selectivity over
normal healthy MRC9 lung cells. To determine this, we elected to target the epidermal
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growth factor receptor (EGFR) that is highly overexpressed on the lung cancer A549 cells
in comparison to the healthy lung MRC9 cells with a normal much lower expression of
EGFR. We targeted the EGFR by conjugating an EGFR targeting ligand, GE 11, with the
amino acid sequence YHWYGYTPQNVI, to the surface of the SLB fused to the MSNP to
foster specific binding to the highly overexpressed EGFR on the lung cancer A549 cells.7578, 112-119

We demonstrated a shape enhanced primarily caveolin 1 dependent cellular internalization
pathway for EGFR-targeted protocells with a small amount of clathrin-dependent
endocytosis. The EGFR-targeted MSNP2 rods with intermediate aspect ratios were shown
to have a greater level of cellular internalization efficiency than the EGFR-targeted
spherical MSNP0 or MSNP EISA with lower aspect ratios. The preferential cellular uptake
of EGFR-targeted MSNP2 rod shaped protocells over EGFR-targeted spherical shaped
protocells occurs by their ability to provoke a cellular mechanosensory response with more
favorable internalization. We correlated the higher amount of internalization of the EGFRtargeted MSNP2 protocells with previously published computational and mathematical
models72, 79 to result from the more favorable thermodynamics of the nanoparticle local
curvature interaction at initial contact with the cell plasma membrane. The rod shaped
EGFR-targeted protocells are able to interact with the cell lipid bilayer such that their tip
comes into contact first with the lipid bilayer allowing for lower penetration energy
compared to the spherical shaped EGFR-targeted protocells. The increase in the capacity
for penetration at the cell plasma membrane of the rod shaped EGFR-targeted MSNP2 was
demonstrated by flow cytometry, fluorescence plate reading, TEM and TEM of cell
monolayers studies.
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Chapter 2
Shape and Surface Chemistry Dictate Cellular Internalization
Pathways of Mesoporous Silica Nanoparticles.
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Abstract
Nanoparticle size and surface charge have been recognized as strong determinants of NP
internalization, but less attention has been given to shape. In this research we have shown
that the shape of mesoporous silica nanoparticles as well as their surface chemistry are
critical aspects in achieving higher selective cellular uptake of targeted protocells. Herein,
we demonstrate that by fusion of a 4 nm thick, conformal, zwitterionic, supported lipid
bilayer (SLB) onto MSNP rods or spheres, forming a construct referred to as a protocell,
that we preserve the AR but abolish the non-specific, shape-stimulated macropinocytotic
pathway of internalization in A549 cells. This indicates that the cell's shape sensory system
is modulated by non-covalent electrostatic and hydrogen bonding interactions between
silanols (and amine groups) present on the bare MSNP surface and the biomolecular
components of the cell membrane. Furthermore we establish a selective, shape-stimulated
internalization pathway for targeted rod-shaped protocell AR~1.8-2.3 by conjugation of
the SLB with the ligand GE 11, which binds to EGF receptors highly over-expressed on
A549 cells. Flow cytometry studies of the effects of chemical inhibitors on nanoparticle
cell uptake, along with confocal microscopy colocalization and TEM studies were
performed with A549 cells. The results demonstrated a change in the shape-stimulated
internalization pathway from non-specific macropinocytosis for anionic bare rod-shaped
MSNP to a selective, shape-enhanced, primarily, caveolae-dependent pathway for
zwitterionic targeted rod-shaped protocells.
KEYWORDS. EGFR (epidermal growth factor receptor), aspect ratio, shape, caveolaedependent endocytosis, macropinocytosis, mesoporous silica nanoparticles, targeted
nanoparticles, cellular mechanism of internalization.
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Introduction
Nanocarrier systems (NCS) such as mesoporous silica nanoparticles (MSNP), lipid bilayer
encapsulated MSNP, liposomes and polymer nanoparticles are being intensively studied as
they have the potential to increase the availability of cargo delivered to target cells and
tissues while reducing harmful side effects. Additionally, the packaging of drugs within an
NCS allows delivery of the undeliverable, viz cargos that would otherwise be too insoluble,
toxic, and/or fragile to be delivered as free drugs. Despite major advances in developing
new classes of NCSs that deliver combined therapeutics and diagnostics (i.e. theranostics)
or incorporate appropriate environmentally triggered gating and release strategies, there
remains a limited understanding of nanoparticle internalization mechanisms and their
dependencies on size, shape, and surface chemical properties. 11, 15-16, 51-52, 56, 67, 80-94 This is
presumably due to the difficulty in independently varying these physicochemical properties
for a particular NCS class. Additionally, our knowledge of the various internalization
mechanisms, macropinocytosis, phagocytosis, clathrin-dependent or independent
endocytosis, caveolae-dependent endocytosis and many more11-12, 15-16, 18, 20, 24, 33, 42-44, 51-52,
56, 67, 80-98

are largely based on internalization of ‘natural’ objects like viruses, bacteria,

growth factors, and other molecular components as opposed to NCS, which incorporate a
more diverse range of chemistries and physicochemical properties. Understanding and
controlling NCS internalization is of paramount importance for maximizing the efficacy of
nanoparticle-based therapeutics as the internalization mechanisms have different rates and
efficiencies and direct distinct intracellular trafficking pathways that can be important for
the ultimate delivery of the drug or cargo to the target, e.g. cytoplasm or organelle. In an
effort to enhance the knowledge on how cells mechanistically sense and internalize NCS,
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the research here will study differently shaped MSNP with three different sizes and five
different surfaces using two different cell lines (one cancer and one normal).
The diverse accepted molecular pathways of endocytosis are depicted in Figure 3. These
cellular internalization processes allow cells to acquire and respond to extracellular and
intracellular environmental stimuli.

18, 20

Two forms of endocytosis involving larger

volumes of membrane are macropinocytosis and phagocytosis, shown on the left side of
Figure 3 along with chemicals that inhibit these pathways.20 Morphological differences
between these two forms of endocytosis can be observed by transmission electron
microscopy with macropinocytosis leading to high levels of membrane ruffling upon
introduction of extracellular fluid phase markers (such as growth factors) and phagocytosis
resulting in phagosomes that take on the shape of the cargo being transported.

24

The

process of macropinocytosis starts with membrane ruffling and filopodia protrusions that
encompass an area of the extracellular fluid followed by formation of the macropinosome
by fusion of the protrusion back to the plasma membrane and subsequent further cellular
internalization of the macropinosome.20,

24

Traditionally phagocytosis is a receptor-

facilitated and actin-requiring process that occurs in a zipper-like or trigger-like fashion.
Phagocytosis takes on the shape of its cargo via membrane extensions leading to a
protruding cup enveloping the cargo or continual development of invaginations
surrounding the cargo to be internalized.20, 24 The small G protein, Rac1, and actin proteins
have been shown to be required in both macropinocytosis and phagocytosis. Other proteins
implicated in macropinocytosis
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Figure 3: Cellular pathways of endocytosis along with their respective chemical
inhibitors.
Macropinocytosis, phagocytosis, clathrin-dependent & caveolin-dependent endocytosis
are four main mechanisms of cellular internalization. Macropinocytosis involves
cholesterol, actin & microtubules w/shuttling from macropinosome to lysosome20, 24, 33, 99;
inhibition is by amiloride, nocodazole (noco), cytochalasin D (cytoD), & methyl-cyclodextrin (MBCD) which prevent Rac1/Cdc42 signaling99-100, disrupt microtubules101102
, inhibit actin polymerization101 & inhibit membrane ruffling99, 101, respectively.
Phagocytosis involves cholesterol, actin & microtubules w/shuttling to the endolysosomal
pathway20, 24, 30, 103; inhibition is by noco, cytoD, & MBCD which disrupt microtubules101102
, inhibit actin polymerization101 & inhibit membrane protrusions99, 101, respectively.
Clathrin-dependent endocytosis involves clathrin & clathrin adaptors w/cargo shuttling to
the early endosome (EE) & endolysosomal pathway.20, 24 Dansylcadaverine inhibits it by
lowering the level of free clathrin accessible for interaction at the plasma membrane.104-105
Caveolin-dependent endocytosis involves cholesterol, actin & microtubules for trafficking
within the cell.20, 42-44 Intracellular shuttling for caveolin-dependent internalization are
either to the caveosome, where cargo is shuttled to endoplasmic reticulum (ER) or to the
EE; or to multivesicular bodies (MVB) & subsequent shuttling to lamellar bodies (LB); or
shuttling to the Golgi apparatus.20, 43-44, 106-107 Caveolin endocytosis inhibition by MBCD
extracts cholesterol from cellular membranes preventing assembly of caveolar structures.20,
101
*Note Symbol key on right side. PD153035, EGFR inhibitor, is on right side &
represents inhibition of the EGF receptor upon ligand conjugation. 108
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include PAK1 (serves to activate Cdc42/Rac1 by phosphorylation), PI3K, Ras and Src
(stimulate macropinocytosis). Phagocytosis can involve other small G proteins
Arf6/Cdc42/RhoA, depending on the type, and amphiphysin 1, IQGAP1, Rho kinase and
adhesion proteins.20,
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Macropinocytosis is inhibited by the chemicals amiloride,

nocodazole, cytochalasin D, and methyl--cyclodextrin, shown in Figure 3. Formation of
macropinosomes is distinctively vulnerable to inhibition by amiloride, an inhibitor of
Na+/H+ exchangers shown in the upper left side of Figure 3. The unique inhibition of
macropinocytosis and not the other routes of endocytosis by amiloride is due to an
exceptional sensitivity of the lowering of submembranous pH leading to the impediment
of actin reorganization promoting GTPases, Rac1 and Cdc42, activation; thus, preventing
plasma membrane ruffling, shown above on the left side of Figure 3.

99-100

The chemical

nocodazole inhibits macropinocytosis by disrupting microtubule organization reported to
be associated with cytoskeletal actin re-structuring, see Figure 3. 33, 101-102 Cytochalasin D
is commonly used to inhibit actin polymerization hindering plasma membrane ruffling
necessary for macropinocytosis shown in Figure 3.

24, 101

Cholesterol is a necessary

component to allow activated Rac1 to participate in membrane ruffling. The extraction of
cholesterol from cellular membranes by methyl--cyclodextrin blocks macropinocytosis
through preventing membrane ruffling depicted in Figure 3. 99, 101 Phagocytosis is inhibited
by nocodazole, cytochalasin D and methyl--cyclodextrin, shown in Figure 3. Nocodazole
has

the

effect

of

disrupting

microtubules

necessary

for

the

proper

corresponding arrangement of organelles, as well as, orchestrating the movement of
required vesicles and molecules to the site of phagocytosis.

30, 101

The inhibition of actin

polymerization by cytochalasin D blocks membrane extensions and membrane vesicle
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formation.

20, 24, 30, 101

Extraction of cholesterol from cellular membranes by methyl--

cyclodextrin inhibits membrane extensions and membrane vesicle formation by inhibiting
the initiating signals (PI3K and Lyn). 99, 101, 103
The other two well-studied pathways of cellular internalization are clathrin-dependent and
caveolae-dependent endocytosis, shown on the right side of Figure 3 along with different
chemicals used to inhibit these pathways. Clathrin-dependent endocytosis involves the
formation of a trimer of heterodimers (one heterodimer contains one heavy and one light
chain) to create a triskelion upon binding of ligands to transmembrane receptors or cargo.
20, 24

The trimer of heterodimers then form a lattice-like structure around the vesicles

containing the cargo with involvement of other cytosolic proteins and BAR (Bin
Amphiphysin Rvs) domain containing proteins, like amphiphysin and endophilin, to allow
for scission from the membrane carried out by dynamin GTPase followed by shuttling to
the

early endosome.

20,

24

Clathrin-mediated

internalization

is

inhibited

by

monodansylcadaverine (dansylcadaverine) that serves to lower the level of free clathrin
accessible for interaction at the plasma membrane by stabilizing clathrin coated pits. 104-105
Caveolae mediated endocytosis traditionally involves flask shaped invaginations in the
plasma membrane that allow for uptake of extracellular molecules into the cell by specific
receptor binding. The main component of caveolae in non-muscle cells is caveolin 1.
Caveolin 1 serves as a cholesterol and fatty acid binding protein that forms oligomers with
membrane domains rich in cholesterol at the initial formation of the caveola. 42 The stable
cellular cortical actin network allows the maturing caveola to be kept near the cell
membrane; upon release of the caveola from the plasma membrane the actin cytoskeleton
undergoes rearrangement. Release of the mature caveola involves the scission protein,
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large GTPase, dynamin II, a process regulated by Src kinases (tyrosine kinases) and protein
kinase C.

43, 44

Once the caveolae is released from the plasma membrane the cellular

microtubules step in to assist in shuttling the newly released caveola to the early endosomes
or caveosomes.

44

Caveolae mediated endocytosis is inhibited by methyl--cyclodextrin

that serves to extract cholesterol from cellular membranes preventing assembly of caveolar
structures, shown in Figure 3.

20, 101

Nocodazole and cytochalasin D inhibit caveolin

mediated endocytosis by preventing microtubule recruitment to the caveolae and stopping
actin recruitment to assist in forming the mature caveolae. 43-44, 101
In research to date focused on understanding the relationship between the cell and
nanoparticle interface during binding and internalization, 15, 18, 51, 67, 80, 83-86, 94, 109-110 it has
been concluded the size, shape, nanomaterial composition and surface chemistry of
nanoparticles are crucial in dictating nanoparticle/cellular interactions. 11, 15-16, 51-52, 67, 80-82
Investigations into the rate and molecular mechanism of cellular uptake, intracellular
localization and biocompatibility have been carried out using nanoparticles with varying
aspect ratios to gain insight into the effects of shape on the interaction of the nanoparticles
with the cellular interface. 12, 15, 18, 20, 24, 42-44, 67, 81-83, 87-89, 93, 95-98, 109 Noteworthy is recent
research carried out with the use of an engineered library of cationic, fluorescently labeled
MSNP with identical surface chemistries (zeta-potential in water = +13.0-17.1),
comparable diameters (~ 80 nm), but differing aspect ratios (AR), ranging from ~1
(spherical) to 3 (rod). 15 This study determined that cationic rod-shaped MSNP with AR ~
2.1-2.5 were taken up by HeLa and A549 cancer cell lines in significantly larger quantities
(by 40 to 70-fold) than spherical MSNP or rods with smaller or larger AR by a nonselective macropinocytosis route of cellular internalization.15
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By comparison, a study employing TiO2 nanoparticles (NPs) with a diameter of 50 nm
indicated A549 cellular internalization of the TiO2 NPs was possible only with aggregates
and was mediated by a phagocytic cellular internalization mechanism. 14 Other research
investigating the pathway of cellular uptake for meso-tetra (carboxyphenyl) porphyrin
(TCPP) spherical like nanoparticles with an average diameter of 65 nm by SW480 cells
found by chemical inhibition studies, western blot experiments and RT-PCR that the
nanoparticles were taken up by a clathrin mediated pathway.

111

A different study looked

into the cellular mechanisms of internalization of hydrophobically-modified chitosan (Npalmitoyl chitosan) spherical nanoparticles with a diameter of 207.1±4.3 nm and a zeta
potential of 3.7±0.2 in HT1080, human fibrosarcoma cells.96 They determined by chemical
inhibition studies, confocal microscopy colocalization and flow cytometry studies that the
hydrophobically-modified chitosan (N-palmitoyl chitosan) spherical nanoparticles were
internalized by a caveolae dependent endocytic route. After internalization of the
nanoparticles, they were shuttled transiently to the caveosomes followed by trafficking to
the endosomal pathway. 96 These limited studies support the idea that cellular uptake of
nanoparticles is influenced by the ability of cells to actively ‘sense’ both nanoparticle shape
and surface chemistry.
The main aim of this research was to determine the effects of MSNP shape, aspect ratio,
polydispersity and surface chemistry on their ability to be recognized and internalized by
the cell’s active sensory system. We hypothesized, based on previous studies carried out in
our laboratory11, 52, 56, 90-92, that the fusion of a conformal zwitterionic 4 nm thick supported
lipid bilayer (SLB) on a MSNP would preserve its nominal size and shape but diminish the
ability for the cell’s active sensory system to recognize the MSNP due to obscuration of
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surface silanols Si-OH and deprotonated silanols Si-O-, which can interact with cell
membranes via hydrogen bonding and electrostatic interactions, respectively. We found
that doing so preserved the MSNP aspect ratio but abolished the non-specific, shapestimulated macropinocytotic pathway for A549, non-small cell lung (NSCLC) cells, and
MRC9, healthy lung fibroblast cells, indicating that the cell sensory system is modulated
by non-covalent electrostatic and hydrogen bonding interactions between the silanols (and
amines) on the MSNP surface with the biomolecular components of the cell membrane.
The second aim of this research was to determine if, having turned off non-specific shapeinduced macropinocytosis by virtue of an SLB, we would be able to modify the surface
chemistry of the MSNP to establish a specific shape-induced internalization pathway for
uptake into cancerous A549 cells and not the corresponding normal MRC9 cells. To
investigate this, we chose to conjugate an EGFR targeting ligand, GE 11, with the amino
acid sequence YHWYGYTPQNVI, to the surface of the SLB encasing the MSNP to
promote selective binding to EGFR, which is highly overexpressed on the A549 cells in
comparison to the MRC9 cells.75-78, 112-119 Importantly, we demonstrate a selective EGFRmediated, predominantly caveolae-dependent, non-macropinocytotic pathway that exhibits
a strong shape dependence. EGFR-targeted MSNP2 moderately polydispersed rods with
AR ~2.1 have a significantly higher internalization efficiency than moderately
polydispersed or highly polydispersed spherical MSNP0 and MSNP EISA with lower
aspect ratios. Ultrastructural TEM intracellular analysis of A549 cell monolayers showed
the internalized EGFR-targeted protocells to be further trafficked to multivesicular bodies
and to the lamellar bodies in the A549 cells bypassing a degradative fate in the
endolysosomal pathway.
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Results and Discussion
Synthesis and Physiochemical Characterization of MSNP and Protocells.
Mesoporous silica nanoparticles (MSNP) were generated by aerosol-assisted evaporation
induced self-assembly (MSNP EISA) or by a colloidal sol-gel process (MSNP0 and
MNSP2) as described in the Materials and Methods Section. Corresponding EGFRtargeted protocells were formed by subsequent fusion of liposomes (nominal composition
60 wt% DOPC [1.5 mg]: 5 wt% DOPE [0.125 mg]: 30 wt% cholesterol [0.75 mg]: 5 wt%
PEG lipid [0.125 mg]) onto the MSNP surface followed by conjugation of a GE11 targeting
peptide, described in the Materials and Methods section. The morphology of the bare
spherical MSNP0 and MSNP EISA as well as the rod-shaped MSNP2 are shown in the
TEM images presented in Figure 4A. MSNP EISA particles were formed by an aerosol
process using CTAB as the structure directing agent followed by calcination at 500˚C (to
remove the surfactant and further condense the silica framework). EISA particles are
spherically shaped with an aspect ratio ~1, an average diameter of ~123.7nm±80 nm and
a broad particle size distribution attributable to that of the aerosol generator.11,

52, 56

Importantly in this study the MSNP EISA particles were used as a spherical particle control
to help establish the influence of size polydispersity in addition to shape on internalization.
MSNP0 samples were formed by a colloidal process using CTAB followed by solvent
extraction of CTAB. MSNP0 are approximately spherically shaped with an aspect ratio AR
= 1-1.2 and a moderately uniform diameter averaging ~115±19 nm. MSNP2 particles are
formed by a colloidal process using CTAB plus the co-surfactant perfluorooctanoic acid
followed by solvent extraction. MSNP2 are moderately uniformly sized rod shaped
cylinders with dimensions of 188.7±55 nm /90±16nm, and AR = 1.8-2.3.
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MSNP EISA

MSNP0

MSNP2

B
Figure 4A and 4B: Physiochemical Characterization
of the MSNP.
(A) Transmission Electron Microscopy (TEM) of MSNP
exhibiting different AR values or different synthesis
routes. The top, middle and bottom images are of the
following, respectively: spherical MSNP EISA with the
aspect ratio = ~1.0, average diameter ≈ 123.7 nm,
uniform pore size = 2.5 nm; spherical MSNP0 with the
aspect ratio = ~1.0-1.2, average diameter ≈ 115 nm, uniform pore size = 2.5 nm; rod
cylindrical MSNP2 with aspect ratio = ~1.8-2.3, with average dimensions ≈ 133.8243.5/74-106 nm, uniform pore size = 2.5 nm. Scale bars from left to right, 200 nm,
100 nm and 50 nm. (B) X-ray Diffraction (XRD) data for MSNP0, MSNP2 and MSNP
EISA samples, obtained using Cu K radiation (PANaltyical X'Pert PRO
powder diffractometer).
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Small-angle powder X-ray diffraction (XRD) of the MSNP EISA sample is consistent
with a cubic phase.10 Small-angle powder XRD analysis of MSNP0 and MSNP2
samples showed three well-resolved peaks that can be indexed as the 100, 110 and 200
reflections of a hexagonal (p6m) mesophase as is typical of so-called MCM-41 like
colloidal processing, shown in Figure 4B. Direct TEM imaging in Figure 4A right
panels confirms the cubic and hexagonal symmetries determined by XRD. The pore
size of the samples determined from analyses of the desorption branches of the
respective nitrogen sorption isotherms was approximately 2.5 nm diameter for all three
sample types (see Table 1). The Brunauer-Emmett-Teller (BET) surface areas of EISA
and MSNP0 samples were 1080 and 1078 m2/g. The BET surface area of the MNSP2
sample was 897 m2/g.
The graphic depiction of the MSNP as-prepared,

after amination with

aminopropyltriethoxysilane (APTES) to enable dye conjugation, after amination and
dye conjugation, and, in the case of protocells, after dye conjugation and encapsulation
within a PEGylated supported lipid bilayer (SLB) and after conjugation of the SLB
with the GE 11 targeting ligand are shown in Figure 5. The DLS and zeta-potential
values for the MSNP0, MSNP2 and EISA prepared as mentioned above are listed in
Table 1.
The DLS of the MSNP in RPMI media show a large increase in size indicating an
increase in agglomeration of the particles. The DLS value of the MSNP in CRPMI
showed a reduction in size compared to the DLS values in RPMI. This can be attributed
to increased colloidal stability due to protein adsorption from the fetal bovine serum in
the CRPMI. The polydispersity index of the MSNP EISA particles is greater than
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Table 1. Physicochemical Characterization of MSNP
samples
MSNP0
aspect ratio
pore diameter (nm)
surface area (m2/g)
Bare MSNP no am, no dye
size in 0.5 X PBS, nm/PDI
zeta-potential (mV) in 0.5X PBS
Bare MSNP with am, no dye
size in H2O, nm/PDI
zeta-potential (mV) in 0.5X PBS
Bare MSNP with am, with dye
size in H2O, nm/PDI
size in RPMI, nm/PDI
size in CRPMI, nm/PDI
TEM size, nm
zeta-potential in (mV)
H2O/CRPMI/0.5X PBS
MSNP with am, with dye
and SLB w PEG
size in 0.5X PBS, nm/PDI
Cryo TEM size, nm
zeta-potential (mV) in 0.5X PBS
MSNP with am, with dye and
EGFR-targeted SLB
size in 0.5X PBS, nm/PDI
zeta-potential (mV) in 0.5X PBS

MSNP2

MSNP EISA

1~1.2
2.5
1077.9

1.8~2.3
2.5
896.9

~1.0
2.5
1080

225±3/0.15
-20.57±1.69

253±42/0.22
-21.37±2.14

332±3/0.28
-27.97±1.72

230±6/0.25
12.7±0.12

341±7/0.22
11.3±0.3

335±18/0.3
13.2±2.84

233±14/0.19
1277±15/0.45
249±3/0.16

258±20/0.29
1487±32/0.31
353±7/0.22

115±23
-21.5±0.56/
-11.43±0.23/
-12.4±0.69

190±51/90+16
-25.3±0.9/
-11.4±0.36/
-12.6±0.36

314±12/0.28
1591±77/0.4
9
346±34/0.36
123.7±55
-30.3±1.76/
-12±0.44/
-12.97±0.67

283±26/0.32
115±19
-4.57±0.36

307±6/0.25
188.7±55/90± 16
-3.48±2.27

394±55/0.38
123.7±80
-4.38±1.15

307±5/0.3
-3.09±2.82

309±16/0.32
-3.88±1.44

410±5/0.38
-4.19±0.69

Table 1: Physiochemical Characterization of MSNP.
Zeta potential & DLS measurements were taken of nanoparticles at a concentration of ~125
µg of MSNP/mL in either water (pH=7), RPMI no FBS, complete RPMI with 10% FBS
(pH=7.4), CRPMI, or 0.5X PBS (pH=7.4), using a Zetasizer Nano (Malvern;
Worcestershire, United Kingdom). Zeta Potential & DLS were measured for each MSNP
as-prepared with the following modifications: Bare un-aminated no dye (Bare MSNP no
am, no dye), Bare aminated no dye (Bare MSNP with am, no dye), Bare-aminated with
Dye & FBS coating (Bare MSNP with am, with dye), Non-targeted supported lipid bilayer
with PEG 2000 PE 18:1 protocells (MSNP with am, with dye and SLB w PEG) & EGFRtargeted supported lipid bilayer protocells (MSNP with am, with dye & EGFR-targeted
SLB), for zeta potential n=3, DLS n=3. The Bare MSNP were dispersed by sonication of
stock solutions in ethanol for 15 s before being aliquoted, centrifuged at 14,000 g for 10
minutes at 4C with 5 subsequent water washes & centrifugation at 14,000 g for 10 minutes
at 4C & resuspension to give [1 mg/mL] with sonication for 15 s. The Bare MSNP with
dye were then coated with FBS, by mixing the MSNP in water with 5% FBS before
addition to either water (pH=7), RPMI, CRPMI, or 0.5X PBS (½ 1X PBS mixed with ½
Molecular Grade water) & sonication for 15 s. MSNP with am, with dye & SLB w PEG or
EGFR-targeted SLB were resuspended in 0.5X PBS at [1 mg/mL] with ~125 µg of
MSNP/mL added to 0.5X PBS & bath sonicated briefly. Size by Cryo TEM or TEM were
analyzed using ImageJ software for MSNP with Non-targeted SLB with PEG n≥30 &
MSNP bare n=185. Note the DLS size of the rod shaped particles can be skewed due to the
shape of the particle being non-spherical.126
41

Figure 5: Depiction of Nanoparticles used in the study.
The graphic depiction of the nanoparticles used in the study. The long name and
abbreviated name in parenthesis are how the nanoparticles are listed in Table 1. The
additional abbreviations are used to describe the nanoparticles in other section of the
writing here in conjunction with the specific MSNP name given in Figure 4A.
MSNP0 and MSNP2 particles consistent with their greater size polydispersity resulting
from aerosol generation, shown in Table 1. ImageJ software was used to assess Cryo TEM
images of the MSNP with SLB and PEG to estimate size and size polydispersity, n≥30.
The TEM analysis indicated an increase in polydispersity of the spherical MSNP EISA
with a diameter of 123.7 nm ± 80 nm and aspect ratio of ~ 1 versus the moderately
polydispersed spherical MSNP0 with a diameter of 115 nm ± 19 nm and aspect ratio of ~
1-1.2 (Table 1). The rod MSNP2 had the dimensions of 188.7 nm ± 55 nm/90 nm ± 16 nm
and aspect ratio of 1.8-2.3 (Table 1). For the MSNP0, MSNP2 and MSNP EISA, bare
MSNPs exhibited a slightly smaller DLS size in DI water than corresponding protocells
prepared with PEGylated SLB or PEGylated SLB plus targeting ligand GE 11 indicating a
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size increase as expected for a MSNP-supported lipid bilayer as demonstrated previously90,
127

, accompanied here by modest aggregation. The zeta potential values are highly negative

for all three of the unaminated bare MSNP as expected due to the acidity of surface silanols.
It should be noted that the bare MSNP with amine modification (by the use of APTES)
have a positive zeta potential that becomes progressively more negative by dye
conjugation. Here the negative charge of the aminated MSNP after conjugation with
fluorescent dye indicates that the amine groups have been largely reacted. The bare MSNP
aminated with dye start off with a more negative zeta potential and get more positive upon
incubation with CRPMI due to protein adsorption. The zeta potential of the bare MSNP
becomes more positive and closer to neutral upon fusion of the zwitterionic supported lipid
bilayer indicative of a complete SLB.90 Neither PEGylation nor conjugation with the
EGFR-targeting peptide had a substantial influence on the zeta potential of protocells,
where all zeta potentials are observed to be between -3.09 mV and -4.57 mV consistent
with that of the zwitterionic liposomes used to prepare protocells.
Using a fluorescence plate reader, we determined all dye conjugated MSNP exhibited a
linear dependence of fluorescence intensity on mass and that equal masses of the different
particle types had comparable fluorescence intensities. This follows from the comparable
surface areas (m2/g) and pore sizes of different particle types that allow all interior surfaces
to be equally aminated and dye conjugated. Based on the geometry of the particles (spheres
or rods) and dimensions determined directly from TEM, we were able to determine the
volume and fluorescence intensity per particle allowing us to normalize flow cytometry
data on a per particle basis (vide infra). (This calculation, shown in Supplemental Figure
S1, Table S1 and Table S2, and using the fluorescence calibration curve data in
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Supplemental Figure S2 indicated that the volume and therefore fluorescence of 1 spherical
MSNP0 and MSNP EISA was approximately 1/2 times that of 1 rod MSNP2).
Cryo TEM was performed to visualize and confirm the formation of supported lipid
bilayers on the bare MSNP surface. Cryo-TEM images were taken of the MSNP samples
after fusion with (nominal composition 65 wt% DOPC [1.625 mg]: 30 wt% cholesterol
[0.75 mg]: 5 wt% PEG [0.125 mg]) liposomes and rapid vitrification in amorphous ice
(Figure 6). We observe a conformal ~4.27±0.39 nm thick lipid bilayer coating surrounding
the spherical MSNP0 and MSNP EISA and rod-shaped MSNP2 (combined

Non-T MSNP2

Non-T MSNP0

Non-T MSNP EISA

Figure 6: Physiochemical Characterization of SLB on MSNP.
Cryo TEM of the protocells with a Non-targeted SLB w/PEG. The lipid bilayer is
highlighted between the two yellow arrows in the images of the MSNP. MSNP2, top left
image, MSNP0, middle image, EISA MSNP, right image.
n=100), consistent with the thicknesses of planar lipid bilayers supported on silica glass,
which have been extensively studied as models of cellular membranes and previous
findings of supported lipid bilayer encapsulated MSNP.90, 127-129, 56 In Figure 6, yellow
arrows depict the conformal SLB; note that the EISA particles’ broad particle size
distribution causes the focusing conditions and resolution of the bilayer to be highly
variable.
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Effects of MSNP Physicochemical Properties on A549 Cellular Uptake
Percent cellular uptake and filopodia formation for the MSNP0, MSNP2 and MSNP EISA
particle types was assessed using flow cytometry and confocal microscopy, Figure 7. The
incubation time was determined after performing a time-dependence study of the
negatively charged bare and zwitterionic EGFR-targeted MSNP with little increase in
cellular uptake occurring at 2 hours for all particles, Supplemental Figure S3. The
approximate number of nanoparticles used for the in vitro experiments can be found in
Supplemental Table S3. The flow cytometry data in Figure 7 (left axis, striped bars) shows
the mean fluorescence intensity (MFI) of the sample groups normalized to the bare rodshaped MSNP2, which showed the highest MFI and was defined to be 100% Nanoparticle
Cellular Uptake as a reference. (In the flow cytometry data the background fluorescence
from A549 cells was accounted for by subtracting the mean fluorescence intensity (MFI)
value of the untreated cell samples from the MFI value of the cell samples treated with
nanoparticles). The anionic bare rod MSNP2 showed a significant 32.4 and 54.4 percent
increase in MFI for cellular uptake compared to the anionic bare spherical MSNP0 and
MSNP EISA particles, respectfully. The negatively charged bare rod MSNP2 also
stimulated the formation of the greatest number of filopodia (Figure 7, right y-axis, solid
bars).
Encapsulation of the typically negatively charged bare MSNP within non-targeted
supported lipid bilayers (SLB) prepared with PEG 2000 (Non-T MSNP), resulted in a
dramatic ≥98 percent decrease in non-specific cellular uptake of the respective protocells
(Figure 7, left y-axis, striped bars). The large reduction of the cellular uptake of the
zwitterionic Non-T MSNP indicates the addition of conformal SLB preserves shape and
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aspect ratio but practically abolishes the non-specific macropinocytotic pathway of
internalization. The modification of the SLB with GE-11 peptide to form zwitterionic
targeted protocells resulted in a significant increase in specific cellular uptake compared to
the corresponding zwitterionic non-targeted SLB prepared with PEG 2000 and without
PEG 2000 for all three different types of MSNP. The increase in cellular uptake for the
zwitterionic EGFR-targeted protocells compared to the zwitterionic non-targeted SLB
prepared with PEG 2000 protocells was found to be 98, 89.3 and 98.78 percent for the
MSNP2, MSNP0 and MSNP EISA, respectively and compared to the zwitterionic nontargeted SLB without PEG 2000 protocells was found to be 92.6, 87.5 and 73 percent for
the MSNP2, MSNP0 and MSNP EISA, respectively. The addition of targeting ligands to
SLB maintains size and shape of the EGFR-targeted protocells and confers a cell specific
binding and internalization pathway. Moreover, the zwitterionic SLB (prepared with PEG
or PEG plus the GE 11 targeting peptide) significantly suppressed filopodia formation for
all protocells compared to the anionic bare MSNP. Supplemental Figure S4 shows the
MSNP and protocell cellular uptake determined on a number of nanoparticles internalized
per cell basis calculated according to the formula presented in Supplemental Figure S5. On
this basis we observe a significant increase of EGFR-targeted MSNP2 cellular uptake over
both the EGFR-targeted MSNP0 and MSNP EISA with a p≤0.05 as well as a large increase
in EGFR-targeted MSNP0 cellular uptake compared to EGFR-targeted MSNP EISA with
a p≤0.05. However, on a percentage basis, the rodlike anionic bare MSNP2 particles and
corresponding zwitterionic protocells show only a 32.4% and 54.4% percent increase in
cellular uptake over the anionic bare spherical MSNP0 and MSNP EISA particles,
respectfully; and a 64% and 74.9% increase over the zwitterionic spherical MSNP0 and
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Figure 7: Biofunctionalization effects on cellular uptake of MSNP, non-targeted
protocells and EGFR-targeted protocells in A549 cells.
Flow cytometry was performed on A549 cells incubated with 20 µg of MSNP for 2 hours
at 37°C, 5% CO2, prepared for flow cytometry, re-suspended in 1 ml of PBS, and mean
fluorescence intensity on FL1 channel was read using a BD Biosciences LSR Fortessa flow
cytometer at the UNM Shared Flow Cytometry and High Throughput Screening Resource
Center. Left y-axis, % Cellular Uptake (dashed bars) was calculated by setting the relative
mean fluorescence intensity (MFI) of the FL1 channel for the Bare MSNP2 as the 100%
cellular uptake reference for comparison of the FL 1 MFI of the different nanoparticle
sample groups. MSNP with the following surface modifications: SLB with PEG 2000 (SLB
w/PEG), SLB without PEG 2000 (SLB no PEG) or EGFR-targeted protocells (EGFR-T),
n=3. The Filopodia (grey solid bars) were counted for n=30 cells by inspection of confocal
microscopy images with phalloidin, an f-actin stain. The statistical significance of a double
sided T-test p ≤ 0.05 is representative for the following comparisons: MSNP2 Bare MFI to
other MSNP sample groups for the *; Non-T compared to EGFR-T within same MSNP
type for the $; MSNP Bare group Filopodia/cell compared to respective Non-T and EGFRT MSNP sample group for the +.
MSNP EISA protocells, respectively, shown in Figure 7. Notably the aspect ratio
enhancement of the rodlike anionic bare MSNP over the spherical like anionic MSNP on
a percentage basis is greatly reduced here in comparison to a previous study using
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positively charged rod and spherical MSNP (Zeta potential = 13 mV for the rod and Zeta
Potential = 15.7 mV for the spherical MSNP) with comparable aspect ratios and observed
enhancement factors of rods (AR = 2-3) over spheres of 40-70 fold.15 This suggests that
bare MSNP with a cationic surface charge exhibit a much greater sensitivity to the
influence of shape on the level of cellular of internalization compared to anionic MSNP.
A549 Cellular Uptake Mechanisms of Anionic Bare MSNP and EGFR-targeted
Protocells

Cellular uptake inhibition studies with flow cytometry were performed using a variety of
chemical inhibitors or low temperature (MSNP incubation for 2 hours at 4°C, which
suppresses metabolic activity) to delineate any differences in the cellular uptake
mechanisms between anionic bare MSNP and zwitterionic EGFR-targeted protocells. See
Supplemental Table S4 for a description of the inhibitor function. The non-targeted SLB
encapsulated MSNP had negligible cellular uptake and were thus excluded from the
inhibition studies presented in Figure 7.
One of the greatest differences in inhibition of A549 cellular uptake of nanoparticles
occurred with the chemical amiloride, a Na+/H+ exchange inhibitor (known to be a specific
inhibitor of macropinocytosis). The anionic bare MSNP (Figure 8) showed a significant
decrease in A549 cellular uptake with cells treated with amiloride. In contrast, the
amiloride treatment of the cells did not have a significant impact on A549 cellular uptake
of the zwitterionic EGFR-targeted protocells (Figure 9).100 The inhibition of cellular uptake
of the anionic bare MSNP with amiloride but not the zwitterionic EGFR-targeted protocells
indicates the anionic bare MSNP are taken up by a macropinocytosis route; whereas, the
zwitterionic EGFR-targeted protocells are taken up by a different non-macropinocytotic
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cellular mechanism. The chemical inhibitor monodansylcadaverine, known to inhibit
clathrin coated pits, did inhibit the anionic bare spherical MSNP0 and anionic bare rod
MSNP2 but not to the same extent with polydispersed MSNP EISA; however, it had no
significant effect on the cellular uptake of all three zwitterionic EGFR-targeted
protocells.104-105 The inhibition of the bare anionic spherical MSNP0 and bare anionic rod
MSNP2 by monodansylcadaverine indicates that a portion of the bare anionic spherical
MSNP0 and bare anionic rod MSNP2 were internalized by a clathrin mediated endocytic
pathway. This outcome differs from a previous study where the bare cationic MSNP0 and
bare cationic MSNP2 were not inhibited by monodansylcadaverine and points out the
importance of charge on internalization pathways.15 Interestingly, an additional study
carried out in HeLa cells demonstrated cellular uptake of bare anionic spherical MSNP to
be reduced when clathrin coated pits were inhibited by 450 mM sucrose.67 Taken together,
of these findings show that the change in surface charge of the MSNP0 and MSNP2 from
cationic to anionic allows for an additional clathrin-mediated pathway of cellular
internalization. The lack of a significant decrease in cellular uptake of the bare anionic
spherical MSNP EISA by clathrin-coated pit inhibition with monodansylcadaverine can be
attributed to the larger average size and a reduction on the reliance on the clathrin-mediated
pathway.16, 94, 96 The lack of inhibition of the zwitterionic EGFR-targeted protocells (Figure
9) by monodansylcadaverine indicates that clathrin-dependent endocytosis is not a major
pathway for their cellular internalization. The bare anionic MSNP were inhibited to a
greater extent with the chemical amiloride compared to the monodansylcadaverine
inhibitor showing macropinocytosis to be the predominant route of bare anionic MSNP
cellular internalization.
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Figure 8: Inhibition study to investigate the mechanisms of Bare MSNP cellular
uptake with different inhibitors of cell function.
Flow Cytometry was performed on A549 cells incubated with 20 µg of MSNP for 2 hours
at 37°C, 5% CO2 with & without chemical or thermal inhibition. Mean fluorescence
intensity on FL1 channel was read using a BD Biosciences LSR Fortessa flow cytometer
at the UNM Shared Flow Cytometry and High Throughput Screening Resource Center. %
Cellular uptake of the Bare MSNP was calculated by taking the relative MFI for the Bare
MSNP2 as the 100% cellular uptake reference to compare the MFI of the Bare MSNP2,
Bare MSNP0 and Bare MSNP EISA sample groups against. Inhibition of cellular uptake
was performed by A549 cell media 2 hour pre-treatment (before no NPs) & 2 hour cotreatment (with NPs) with the following: excess free EGFR-targeting peptide (free EGFR
peptide); PD153035 (EGFR TK inhibitor); LDV; Monodansylcadaverine (dansyl);
Amiloride; Nocodazol; Cytochalasin D (cytoD); Methyl-beta-cyclodextrin (MBCD) or
4°C incubation temperature (4C). The statistical significance of a double sided T-test p ≤
0.002 is represented by an * for the comparison of the treatment groups to the Bare MSNP
only within the same MSNP type. The $ symbol represents the statistical significance of a
double sided T-test p ≤ 0.01 for the comparison of the just bare MSNP0 and MSNP EISA
to the just bare MSNP2.

The flow cytometry data presented in Figure 8 for the anionic bare MSNP2, MSNP0 and
MSNP EISA and in Figure 9 for the zwitterionic EGFR-targeted MSNP2, MSNP0 and
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MSNP EISA protocells both similarly show a significant decrease in cellular uptake when
cells are treated with methyl-β-cyclodextrin. The treatment extracts cholesterol from the
cellular membrane resulting in blocking of activated Rac1 participation in membrane
ruffling necessary for macropinocytois to occur and in inhibition of caveolae/lipid raft
formation.99, 101 The reduction in A549 cellular uptake of the anionic charged bare rod
MSNP2, spherical MSNP0 and spherical MSNP EISA in this study by methyl-βcyclodextrin differs from another study where HeLa cellular uptake of cationic charged
bare rod and spherical MSNP were unaffected by Filipin III which sequesters cholesterol
in the plasma membrane, similar to methyl-β-cyclodextrin which depletes cholesterol from
the plasma membrane.15, 99, 101 The differences in these findings may indicate a chargedependent or cell type specific difference in the sensitivity to levels of cholesterol in the
plasma membrane and macropinocytotic uptake of bare MSNP.15 In addition changes in
macropinocytosis have previously been noted to be both cell type specific and surface
charge specific.4-8
Two chemicals nocodazole and cytochalasin D were used to inhibit cytoskeleton
rearrangements. Nocodazole is known to disrupt microtubule formation important in
shuttling of newly formed macropinosomes and caveosomes from the plasma membrane.
Cytochalasin D is known to inhibit F-actin polymerization which key in formation of
macropinosomes and caveosomes as well as shuttling clathrin-dependent endocytic
vesicles away from the plasma membrane. In addition macropinocytosis, clathrindependent and caveolin-dependent endocytosis are all active mechanisms of cellular
internalization.

20, 24, 33, 42-44, 99, 104-105

Both nocodazole and cytochalasin D similarly

strongly inhibited the cellular uptake of the anionic bare MSNP and zwitterionic EGFR51

Figure 9: Inhibition study to investigate the mechanisms of EGFR-targeted protocell
cellular uptake with different inhibitors of cell function.
Flow Cytometry was performed on A549 cells incubated with 20 µg of EGFR-targeted
protocells for 2 hours at 37°C, 5% CO2 with and without inhibition. Mean fluorescence
intensity on FL1 channel was read using a BD Biosciences LSR Fortessa flow cytometer
at the UNM Shared Flow Cytometry and High Throughput Screening Resource Center. %
Cellular uptake was calculated for the 3 different EGFR-targeted protocell sample groups
by taking the relative MFI of the FL1 channel for the EGFR-targeted protocell MSNP2 as
the 100% cellular uptake to compare the MFI of the EGFR-targeted protocell MSNP0 and
MSNP EISA samples. Inhibition of cellular uptake was performed by A549 cell media 2
hour pre-treatment and co-treatment with: excess free EGFR-targeting peptide (free EGFR
peptide (GE 11)); PD153035; LDV; Monodansylcadaverine (dansyl); Amiloride;
Nocodazole; Cytochalasin D (cytoD); Methyl-beta-cyclodextrin (MBCD) or 4°C
incubation temperature (4C). Statistical significance of a double sided T-test p ≤ 0.001 is
represented by * for comparison of treatment groups EGFR-targeted protocells within same
EGFR-targeted protocell type. $ symbol represents statistical significance of a double sided
T-test p ≤ 0.001 for the comparison of the just EGFR-targeted protocell MSNP0 and MSNP
EISA to the just EGFR-targeted protocell MSNP2.
targeted protocells (Figures 8 and 9).101 Furthermore the internalization mechanism of both
anionic Bare MSNP and EGFR-targeted protocells similarly exhibited an energy
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dependence as confirmed by the decrease in cellular uptake at 4°C (Figures 8 and 9).15
Together these inhibition outcomes demonstrate the cellular uptake of the anionic bare
MSNP and the zwitterionic EGFR-targeted protocells although internalized by different
mechanisms both require involvement of microtubule formation and F-actin
polymerization in an active mechanism of cellular internalization. The confocal
fluorescence microscopy images in supplemental Figure S6 of the A549 cells with
inhibitors amiloride, cytochalasin D and methyl-β-cyclodextrin all showed smoothing of
the cell membrane without adverse effects on the integrity of the cell membranes.
Neither the anionic bare MSNP nor the zwitterionic EGFR-targeted protocells showed any
significant decrease in cellular uptake when treated with PD153035, a specific inhibitor of
EGFR tyrosine kinase activity that prevents EGF receptor activation.108 Taken together,
these studies are consistent with the notion that EGF receptor activation is not necessary
for cellular uptake of either anionic bare MSNP or zwitterionic EGFR-targeted protocell.108
The use of the chemical LDV known to inhibit ligand binding to the α4/β1 dimer was to
determine if the cellular uptake of the anionic bare MSNP and zwitterionic EGFR-targeted
protocells involved the α4/β1 dimer.130 The anionic bare MSNP sample groups treated with
LDV showed a small decrease in cellular uptake compared to their respective bare MSNP
groups without inhibition, shown in Figure 8. This small decrease was only seen with the
anionic bare MSNP; whereas, the zwitterionic EGFR-targeted protocell groups were
unaffected (Figure 9). The results of the LDV treatment suggest that neither the anionic
bare MSNP nor zwitterionic EGFR-targeted protocells involve the α4/β1 dimer in their
mechanism of cellular internalization.
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The percentage cellular uptake of the anionic bare MSNP and zwitterionic EGFR- targeted
protocells differed greatly when A549 cells were incubated with excess free EGFR peptide
(GE11), which competitively binds EGF receptors on the cell surface. The bare MSNP
showed no significant change in cellular uptake (Figure 8). On the other hand, EGFRtargeted MSNP2, MSNP0 and MSNP EISA (Figure 9) all showed a significant decrease in
cellular uptake of more than 87% when incubated with excess free GE 11 peptide.67 The
findings from incubating the cells with excess free EGFR peptide (GE 11) shows a
difference in the cellular uptake mechanism for the zwitterionic EGFR-targeted protocells
that requires recognition of the EGFR peptide GE 11 by the A549 cells for cellular uptake
to occur which is not necessary for the cellular uptake of the anionic bare MSNP.
Effect of GE 11 targeting Peptide Density on Protocell Binding Affinity

The effective binding affinity Kd of GE 11 targeted protocells prepared with three different
EGFR targeting peptide densities (high (~2048/protocell), medium (~120/protocell) and
low (~6/protocell peptides) were evaluated using a fluorescence plate reader for A549 and
MRC9 cells at 4°C, where internalization is suppressed (Figure 10), to minimize
confounding effects of nanoparticle internalization. Using a fluorescence plate reader to
determine binding avoided having EGFR cleavage by trypsin affect the binding outcomes.
This study was conducted to determine if the fluidity of the supported lipid bilayer allowed
for lateral diffusivity of the GE 11 targeting peptide and enabled multivalent binding to the
target A549 cell surface receptors. The binding curves for the three different zwitterionic
EGFR-targeted protocells at the three different peptide densities were determined by taking
the fluorescence reading of the cells after being incubated at 4°C with an increasing
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Mid Density (~120 peptides)
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Figure 10: Selective binding characterizations of GE 11 targeting peptide.
(A) Log of apparent binding affinities (Kd) - for 3 types of EGFR-targeted protocells with
3 different peptide densities: high (~2048), medium (~120) and low (~6) incubated with
A549 cells in complete media for one hour on ice (~4 °C), followed with 5X PBS wash.
Fluorescent measurements taken using a Wallac 1420-040 Victor 3V multilabel
fluorescence plate reader in the UNM Shared Flow Cytometry and High Throughput
Screening Resource Center, n=2, error bars represent the 95% confidence intervals. (B)
Visual inspection of selective binding was performed on confocal images of A549 cells
incubated with rod protocells at low, medium (mid) or high peptide densities in complete
media for one hour on ice. The fluorescence confocal images of the mid-plane of the cells
were taken on a Zeiss 510 META confocal microscope with a 63X oil immersion objective
at the University of New Mexico’s Fluorescence Microscopy Shared Resource Facility.
The cell confocal stains: Cell Mask Orange Plasma membrane-red, Dylight 488 MSNP2green and Dapi Cell Nucleus – blue. The White scale bar = 10 µm in the confocal images.
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concentration of EGFR-targeted protocells until the binding maximum Bmax, (the
concentration where no further increase in binding occurs with increasing particle
concentration) was reached (see Supplemental Figure S7). The protocell concentration
corresponding to ½ Bmax of the binding curve is then defined as the apparent binding
affinity, Kd, of the EGFR-targeted protocells since the concentration of binding sites on the
cells are small compared to the concentration of particles.131 The ½ Bmax of the binding
curves for the three different zwitterionic EGFR-targeted protocells at the three different
peptide densities were determined using Prism software and graphed using Excel (Figure
10). As shown in Figure 10, the apparent binding affinities for all three zwitterionic EGFRtargeted protocells were below 1 nM and showed little effect of targeting peptide density.
The targeted rod protocells showed a slightly lower Kd, i.e. greater apparent effective
binding affinity, than the MSNP0 and MSNP EISA spherical protocells. Overall there was
a modest shape dependence (with rod-shaped having lowest but not significantly different
Kd) and no peptide density dependence of Kd. The lack of a significant peptide density
dependence provides evidence that the fluidity of the SLB enables lateral diffusivity and
multivalent interactions of the GE 11 ligands with the target A549 cell. The confocal
images presented in Figure 10 for the MSNP2 targeted protocells incubated at 4˚C for 1
hour show representative patterns of binding to the cell surface with some internalization
shown due to the confocal staining processing steps and are consistent with achieving
EGFR-targeted protocell binding to A549 cells at all peptide densities.
Selective Binding and Internalization of EGFR-targeted Protocells
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Next, we used confocal microscopy to compare the binding and internalization of anionic
bare MSNP and corresponding zwitterionic non-targeted and targeted protocells by lung
cancer A549 cells, displaying high overexpression of EGFR, and control healthy lung
MRC9 cells with normal expression of EGFR, at 37°C.77, 78 As shown in Figure 11, panel
a, where the focal plane is approximately the mid-plane of the cells, anionic bare MSNP
were readily internalized by A549 and MRC9 cells where they appear localized in large
clusters taken up in large in both the A549 and MRC9 cells consistent with a
macropinocytotic internalization pathway. In order to determine the influence of the
conformal zwitterionic SLB on cellular interactions with the MSNP, a non-targeted
supported zwitterionic lipid bilayer modified with PEG 2000 was fused to the MSNP. For
all MSNP samples the conformal zwitterionic SLB resulted in complete abrogation of
binding to either the A549 or MRC9 cells (Figure 11, panel b and e) indicating that the
conformal and complete zwitterionic SLB completely obscured surface silanols Si-OH
and deprotonated silanols Si-O-, which can interact with cell membranes via hydrogen
bonding

and

electrostatic

interactions

to

stimulate

filapodia

formation

and

macropinocytosis. These findings confirm the flow cytometry data in Figure 7 for the A549
cells which showed a significant decrease of cellular uptake of the non-targeted protocells
with PEG 2000 similar to what was seen in the no treatment cells. Introduction of the EGFR
targeting peptide, GE 11, to the fluid SLB resulted in selective binding and internalization
with target lung cancer A549 cells (Figure 11, panel c), whereas there is no apparent
binding and internalization with control healthy MRC9 cells (Figure 11, panel f). A549
cells incubated with the zwitterionic EGFR-targeted protocells showed a discrete punctate
appearance consistent with an endocytotic internalization pathway as opposed to the large
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The images of the mid slice of the cells were taken on a Zeiss 510 META confocal
microscope with a 63X oil immersion objective or a Leica TCS SP8 confocal microscope
with a 63X oil immersion objective at the University of New Mexico’s Fluorescence
Microscopy Shared Resource Facility. The cell confocal stains: Cell Mask Orange or
Phallodin Alexa 633, plasma membrane-red; Dylight 488, MSNP2-green; and DAPI, cell
nucleus – blue.
The white scale bars = 10 µM.
a) Bare
MSNP
A549 cells

58

aggregates seen with bare MSNPs and attributable to macropinocytosis. The lack of
targeted protocells taken up by MRC9 cells indicates that the EGFR targeting peptide, GE
11, directs selective uptake into the target A549 lung conformal and complete zwitterionic
SLB completely obscured surface silanols Si-OH and deprotonated silanols Si-O-, which
can interact with cell membranes via hydrogen bonding and electrostatic interactions to
stimulate filapodia formation and macropinocytosis. These findings confirm the flow
cytometry data in Figure 7 for the A549 cells which showed a significant decrease of
cellular uptake of the non-targeted protocells with PEG 2000 similar to what was seen in
the no treatment cells. Introduction of the EGFR targeting peptide, GE 11, to the fluid SLB
resulted in selective binding and internalization with target lung cancer A549 cells (Figure
11, panel c), whereas there is no apparent binding and internalization with control healthy
MRC9 cells (Figure 11, panel f). A549 cells incubated with the zwitterionic EGFR-targeted
protocells showed a discrete punctate appearance consistent with an endocytotic
internalization pathway as opposed to the large aggregates seen with bare MSNPs and
attributable to macropinocytosis. The lack of targeted protocells taken up by MRC9 cells
indicates that the EGFR targeting peptide, GE 11, directs selective uptake into the target
A549 lung cancer cells and not into healthy lung MRC9 cells (compared in Figure 11,
panels c and f).
Intracellular Trafficking of EGFR-Targeted Protocells

Confocal fluorescence microscopy colocalization experiments were performed to
determine if the zwitterionic EGFR-targeted protocells were trafficked to the early
endosomes after internalization and if clathrin coated pits or caveolin 1 were involved in
59

their mechanism of internalization. Mid-slice images from the confocal imaging z-stacks
in these studies are shown in Figures 12, 13 and 14. To assess endosomal trafficking,
clathrin coated pits or caveolin 1 involvement in internalization of the targeted protocells
the A549 cells were incubated for either 45, 20 or 60 minutes in complete medium (a
shorter incubation time for clathrin pits due to clathrin quickly dissociating form vesicles
upon internalization), respectively, with targeted protocells labeled with dylight 488.28, 29
Then the cells were prepared for staining with the primary monoclonal antibodies and
secondary antibodies. The cells were stained as follows: early endosomes were stained with
early endosome antigen protein (EEA1); clathrin coated pits were stained with clathrin
heavy chain and caveolin 1 was stained with caveolin 1. After staining and cell preparation
z-stack confocal imaging on the samples was performed with a Leica TCS SP8 confocal
microscope with a 63X oil immersion objective (mid-slice images from z-stacks are shown
in Figure 12, 13 and 14). The confocal z-stacks were analyzed for percent colocalization
of the labeled EGFR-targeted protocells and the EEA1, clathrin heavy chain or caveolin 1
by Slidebook 6 software (Intelligent Imaging Innovations, Inc.; Philadelphia, PA).
An early endosome colocalization study was performed to determine if EGFR-targeted
protocells were trafficked to the early endosomes, Figure 12. The EGFR-targeted protocells
showed positive colocalization with early endosomes as follows: EGFR- targeted MSNP2:
38%, EGFR-targeted MSNP0: 42% and the EGFR-targeted MSNP EISA: 37%. Positive
colocalization with early endosomes indicates targeted protocells are trafficked to the early
endosomes during their internalization.
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Figure 12: Trafficking of EGFR-targeted protocells to the early endosome.
A549 cells were incubated for 45 minutes at 37°C and 5% CO2 with each of the following
nanoparticles at 50 µg/mL in media: EGFR-targeted protocells MSNP2, MSNP0 or MSNP
EISA. Z-stack images of the fixed cell samples were taken for the different sample groups
on a Leica TCS SP8 confocal microscope with a 63X oil immersion objective at the UNM
Fluorescence Microscopy Shared Resource Facility. The mid-slice image of each group is
shown above and has been brightness and contrast enhanced for visualization. Quantitative
analysis of the Z-stack confocal images for colocalization between early endosome antigen
protein (EEA1) and nanoparticles was performed using Slidebook 6 software and the
reported % colocalization of the green pixels of the EGFR-targeted protocell with the red
pixels of the EEA1 is reported above with an n=30 cells. Importantly the findings from this
study show positive colocalization of EEA1 with the EGFR-targeted protocells for all three
MSNP types indicating trafficking of the EGFR-targeted protocells to the early endosome.
The cell confocal stains: Early endosomes, EEA1 antibody-red; and Dylight 488, EGFRtargeted protocell MSNP-green. White scale bare = 10 µm

A clathrin colocalization study was performed to determine if clathrin-dependent
internalization was involved in the cellular uptake mechanism of the EGFR-targeted
protocells Figure 13. The targeted protocells were found to have a very low level of positive
colocalization with the clathrin heavy chain with the rod MSNP2 having 16%, the spherical
MSNP0 having 14% and the spherical MSNP EISA having 11%. The very low level of
zwitterionic EGFR-targeted protocell colocalization with clathrin indicates that clathrindependent cell uptake is not a major mechanism of EGFR-targeted protocells cellular
internalization in A549 cells.
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Figure 13: Colocalization study of EGFR-targeted protocells with clathrin coated
pits.
A549 cells were incubated for 20 minutes at 37°C and 5% CO2 with each of the following
nanoparticles at 50 µg/mL in media: EGFR-targeted protocells MSNP2, MSNP0 or MSNP
EISA. Z-stack images of the fixed cell samples were taken for the different sample groups
on a Leica TCS SP8 confocal microscope with a 63X oil immersion objective at the
University of New Mexico’s Fluorescence Microscopy Shared Resource Facility. The midslice image of each group is shown above and has been brightness and contrast enhanced
for visualization. Quantitative analysis of the Z-stack confocal images for colocalization
between clathrin coated pits (clathrin heavy chain antibody) and nanoparticles was
performed using Slidebook 6 software and the reported % colocalization of the green pixels
of the EGFR-targeted protocell with the red pixels of the clathrin is reported for n=20-30
cells. Importantly the findings from this study show little positive colocalization of clathrin
coated pits with the EGFR-targeted protocells for all three MSNP types indicating clathrin
is not a main route of internalization. Cell confocal stains: clathrin coated pits, clathrin
heavy chain antibody-red; and EGFR-targeted protocell MSNP-Dylight 488-green. White
scale bare = 10 µm.
To further investigate the zwitterionic EGFR-targeted protocell mechanism of
internalization, a caveolin 1 colocalization study was carried out to determine if
internalization was mediated by the caveolar route, Figure 14. The EGFR-targeted
protocells were shown to have a moderate level of positive colocalization with caveolin 1
with the rod MSNP2 having 57%, the spherical MSNP0 having 54% and the spherical
MSNP EISA having 42%. The positive colocalization of the targeted protocells with
caveolin 1 indicates that they are taken into the A549 cells by a caveolar mechanism of
internalization. The positive colocalization of the zwitterionic EGFR-targeted protocells
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Figure 14: Caveolin 1 colocalization study to investigate EGFR-targeted protocell
mechanism of internalization.
A549 cells were incubated for 1 hour at 37°C and 5% CO2 with each of the following
nanoparticles at 50 µg/mL in media: EGFR-targeted MSNP2, MSNP0 and MSNP EISA.
Z-stack images of the fixed cell samples were taken for the different sample groups on a
Leica TCS SP8 confocal microscope with a 63X oil immersion objective at the University
of New Mexico’s Fluorescence Microscopy Shared Resource Facility. The mid-slice image
of each group is shown above and has been brightness and contrast enhanced for
visualization. Quantitative analysis of colocalization between caveolin 1 and nanoparticles
was performed using Slidebook 6 software and the % colocalization for the green pixels of
the EGFR-targeted protocell colocalized with the red pixels of the caveolin 1 reported with
an n≥42 cells. This caveolin 1 colocalization study confirms caveolin 1 involvement in
EGFR-targeted protocells mechanism of cellular internalization. Cell stains: caveolin 1
antibody, caveolin 1 -red; and Dylight 488, MSNP-green. White scale bare = 10 µm
with caveolin 1 as well as the early endosome marker EEA1 correlates in part to the ability
of the zwitterionic EGFR-targeted protocells to be internalized by a caveolar pathway into
caveosomes and trafficked in a bidirectional manner to early endosomes as has been
previously noted in the literature. 44, 96 These results combined with the inhibition studies
show that the EGFR-targeted protocells are internalized in a primarily caveolae-dependent,
cholesterol sensitive, energy requiring process that allows them to be shuttled in part to the
early endosomes and caveosomes.
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TEM Investigations of Anionic Bare MSNP and EGFR-Targeted Protocell
Internalization Pathways

TEM ultrastructural analysis of thin sections of A549 cells incubated with Bare MSNP and
EGFR-targeted protocells was performed to study their interaction with the cell plasma
membrane during internalization and further trafficking inside the cell. Thin sections of
A549 cells incubated with anionic bare MSNP or zwitterionic EGFR-targeted protocells
and stained and embedded in epoxy were prepared by using an ultramicrotome (see
Methods). A higher concentration of targeted protocells were incubated with the A549
cells in the TEM cell monolayer study compared to the anionic bare MSNP to compensate
for the decreased level of binding and internalization of targeted protocells compared to
bare MSNPs. Using electron microscopy, we observed membrane ruffling and filopodia
extension and retraction for the bare MSNP2 (Figure 15A) consistent with a
macropinocytotic internalization pathway as expected from the inhibition of cellular uptake
by amiloride (shown in Figure 8) and previous studies which demonstrated non-specific
and macropinocytosis cellular internalization of anionic and cationic bare MSNP. 15, 51 In
contrast, zwitterionic EGFR-targeted MSNP2 protocells did not stimulate filapodia
formation but rather induced formation of plasma membrane invaginations surrounding the
protocells and sinking into the cell, indicative of a non-macropinocytotic pathway (Figure
15B). The images in Figure 16A and Figure 16B indicate a large amount of cellular uptake
of the rod and spherical shaped anionic bare MSNP in large fluid filled vesicles consistent
with macropinocytosis.15 The zwitterionic EGFR-targeted protocells are taken up to a
lesser extent than the anionic bare MSNP. The zwitterionic EGFR-targeted rod particles
are taken up in a manner where the rod approaches the membrane perpendicular to the
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Figure 15A and 15B: TEM ultrastructural analysis of A549 cellular plasma
membrane interaction with nanoparticles
TEM images of A549 cell monolayers after a 3 hour incubation with (A) 50 ug/mL media
of Bare rod MSNP2, seen on the left, or (B) 300 ug/mL of EGFR-targeted rod MSNP2
protocells, seen on the right, at 37°C and 5% CO2. Cells are stained with Osmium Tetroxide
and Uranyl Acetate and Reynold’s lead citrate. Note: cross sections of the bare MSNP2
and EGFR-targeted protocells perpendicular to the plane of imaging appear spherical.
Scale bars = 100 nM
plasma membrane upon initial approach and continues to be wrapped and internalized at
this angle shown in Figure 15B and the Supplemental Figure S8B.
The combination of the perpendicular angle of approach at the plasma membrane of the
anisotropic shaped zwitterionic EGFR-targeted rod protocells and the high affinity
interactions between the EGFR targeting peptide and the receptor allows for more
thermodynamically favorable physical energy requirements of nanoparticle penetration
through a cell plasma membrane compared to the isotropic shaped zwitterionic EGFRtargeted spherical protocells. The sharper local curvature of the tip of the zwitterionic
EGFR-targeted rod shaped protocell having a smaller diameter that remains constant
compared to the larger diameter of the zwitterionic EGFR-targeted spherical shaped
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Figure 16A and 16B: TEM ultrastructural analysis of A549 cellular internalization of
bare MSNP.
TEM images of A549 cell monolayers after 3 hour incubation with 50 ug/mL complete
media of (A) Bare rod MSNP2 or (B) Bare spherical MSNP0, at 37°C and 5% CO2. Note:
cross sections of the bare MSNP2 and EGFR-targeted protocells perpendicular to the plane
of imaging appear spherical. Cells are stained with Osmium Tetroxide and Uranyl acetate
and Reynold’s lead citrate. Scale bars = 2 µM on the left top and bottom and 500 nM on
the right top and bottom images.
protocell allows for a reduction in the nanoparticle contact area with the cell plasma
membrane during initial contact and during internalization. This in turn leads to a decrease
in the disruption area of the plasma membrane for the anisotropic EGFR-targeted rod
66

shaped protocell compared to the isotropic spherical shaped EGFR-targeted protocell. Less
disruption of the plasma membrane for the anisotropic EGFR-targeted rod shaped protocell
compared to the isotropic EGFR-targeted spherical shaped protocell during shuttling across
the membrane lipid bilayer reduces the force required for penetration and crossing through
the plasma membrane.72 The decrease in rigidity and tension during bending of the cell
membrane for the anisotropic EGFR-targeted rod shaped protocell compared to isotropic
EGFR-targeted spherical shaped protocell during nanoparticle penetration, membrane
wrapping and cellular endocytosis leads to a greater cellular internalization of EGFRtargeted rod protocells.71-72,

75, 79

Taken together, the results from the TEM of the cell

monolayers and flow cytometry experiments with the zwitterionic EGFR-targeted
protocells indicate that the anisotropic rod shaped protocells have a thermodynamically
more favorable shape, volume and physical angle of approach that allows for an enhanced
cellular uptake as compared to the isotropic spherical shaped protocells.71-72, 79
Figure 16 depicts both the anionic bare MSNP rods and spheres being located within
macropinosomes with larger amounts of extracellular fluid, which is all encased by a
vesicle membrane. On the other hand, Figure 17B demonstrates the zwitterionic EGFRtargeted protocells having much less fluid in the cellular vesicle, which is also surrounded
by a cellular membrane compared to the anionic bare MSNP in Figure 17A with larger
amounts of fluid in the cellular vesicle. Taken together, the findings shown in Figures 16
and 17 indicate that the addition of the zwitterionic SLB with a GE 11 targeting peptide
has shifted the cellular uptake mechanism from a non-specific macropinocytotic process
to a more selective cellular internalization pathway that includes a caveolin-dependent and
to a lesser degree a clathrin-mediated process.
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Figure 17A and 17B: TEM ultrastructural analysis of bare MSNP2 and EGFRtargeted MSNP2 protocell penetration at the plasma membrane and localization
within the cell.
TEM images of A549 cell monolayers after 3 hour incubation with 50 ug/mL media of
Bare rod MSNP2 or 300 ug/mL media of EGFR-targeted rod MSNP2 at 37°C and 5% CO2.
Note: cross sections of the bare MSNP2 and EGFR-targeted protocells perpendicular to the
plane of imaging appear spherical. Cells are stained with Osmium Tetroxide and Uranyl
Acetate and Reynold’s lead citrate. Scale bars = 100 nM; except for bottom left image,
Scale bar = 500 nM
EGFR-targeted Protocells get Trafficked to Multivesicular Bodies and Lamellar
Bodies
To further confirm the targeted protocell internalization pathway and its shape dependence
without confounding effects of aggregation or polydispersity, additional TEM
ultrastructural analyses were performed using highly monodispersed and colloidally stable
hexagonal prism shaped MSNP (MSNP HP) and spherical large pore dendritic MSNP
(MSNP LP) encapsulated within zwitterionic EGFR-targeted SLBs. As for the targeted
protocells discussed thus far (MSNP synthesis, physiochemical characterization, particle
volume calculations, number of particles used in experiments can be found in supplemental
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information MSNP synthesis, Table S1-S3, S5 and Figure S1 and S9), the images in Figure
18 show the EGFR-targeted MSNP HP and MSNP LP both being taken up into smaller
EGFR-T MSNP HP

EGFR-T MSNP LP

Figure 18: TEM ultrastructural analysis of A549 cellular colocalization of EGFRtargeted MSNP HP and MSNP LP protocells with Multivesicular Bodies and
Lamellar Bodies.
TEM images of A549 cell monolayers after 3 hour incubation with 150 µg/mL media of
EGFR-targeted hexagonal prism MSNP HP (images on top) and EGFR-targeted spherical
MSNP LP (images on bottom) at 37°C and 5% CO2. Cells are stained with Osmium
Tetroxide.
Scale bars in images = 100 nm on the top; 500 nm on the bottom left; 100 nM on bottom
middle and right
vesicles with less extracellular fluid after 3 hours as was demonstrated for the EGFRtargeted MSNP2 in Figures 15B and 17B. The TEM images on the top left and middle of
Figure 18 show the EGFR-targeted MSNP HP localized within vesicles containing
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multivesicular bodies (MVB) (black arrows) and top right show the EGFR-targeted MSNP
HP localized within lamellar bodies (black arrow). While the bottom images in Figure 18
show colocalization of the EGFR-targeted MSNP LP within vesicles with multivesicular
bodies, in the middle image (black arrow), and within the lamellar bodies on the bottom
right (black arrow). The TEM images of the EGFR-targeted MSNP HP and EGFR-targeted
MSNP LP are supportive of a caveolar internalization mechanism, as caveolar cargo has
been noted to be shuttled to multivesicular bodies and further to lamellar bodies, which are
known to be destinations for MVB cargo in pulmonary cells.20, 24,42-44, 106 These results
suggest that EGFR-targeted protocells are taken up in A549 cells by a caveolar
internalization pathway with further trafficking to multivesicular bodies and lamellar
bodies.
Conclusions

This research assessed the role of shape, surface chemistry, and presence of targeting
ligands on directing internalization of mesoporous silica nanoparticles in A549 and control
MRC9 cell lines. The motivation for this research stems from previous research which
demonstrated the aspect ratio of MSNP leads to significant differences in their respective
levels of non-specific cellular uptake.15 Specifically the research showed that cationic
intermediate rod-shaped MSNP (aspect ratio AR = 2) had higher levels of cellular uptake
compared to the corresponding spherical-shaped MSNPs (AR = 1) or higher aspect ratio
MSNP (AR = 4-4.5).15 In addition to these results, further inspiration for the research here
came from our prior findings that fusion of a conformal SLB to MSNPs blocks non-specific
cellular uptake by shielding surface silanols Si-OH and deprotonated silanols Si-O- from
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interacting with cell membranes.

11, 52, 56, 90-92

Based on these previous studies we

hypothesized that the fusion of a conformal zwitterionic SLB to the MSNP would allow us
to preserve shape and aspect ratio while turning off non-specific shape enhanced cellular
uptake; then the addition of a targeting moiety to the SLB fused to the MSNP would allow
for shape enhanced specific nanoparticle internalization to be realized.
Here we have demonstrated that the shape of mesoporous silica nanoparticles as well as
their surface chemistry are crucial aspects in achieving higher selective cellular uptake of
targeted protocells. In this work we have shown that introduction of an EGFR targeting
peptide (GE 11) to the zwitterionic SLB, results in selective binding to A549 cells and
ensuing receptor mediated endocytosis as opposed to non-specific binding and
macropinocytosis as observed for anionic bare MSNPs of identical size and shape. In
addition the results here indicate the rod shaped, EGFR-targeted protocell with AR~1.82.3 as compared to a spherical shaped, EGFR-targeted protocell with AR~1-1.2 results in
shape-enhanced selective cellular uptake in A549 non-small cell lung cancer cells. The
results highlight a stepwise mechanism of cellular internalization for the zwitterionic
EGFR targeted protocell. First the GE 11 (EGFR) targeting peptide on the protocell to
allow for specific binding and recognition of the nanoparticle by the A549 cells, which is
supported by the effective binding affinity Kd study. The competitive binding experiment
with excess free GE 11 peptide and the significant increase in cellular uptake of EGFRtargeted protocells compared to non-targeted protocells. The EGFR-targeting by GE 11
results without undesirable mitogenic signaling, which is indicated by a lack of reliance on
EGFR activation for internalization, demonstrated by chemical inhibition studies. This in
turn allows the EGFR (GE 11)-targeted protocell to interact with the plasma membrane of
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the cell and elicit the cellular endocytic machinery of the cell to allow for cellular uptake.
These findings have been supported by results from flow cytometry, chemical inhibition
studies, fluorescence plate reading, confocal fluorescence microscopy and TEM of cell
monolayers. The rod shaped zwitterionic EGFR-targeted protocells get internalized to a
greater degree than the zwitterionic spherical EGFR-targeted protocells in A549 cells, by
selective, energy requiring, non-macropinocytosis, predominantly caveolae-dependent
endocytosis supported by flow cytometry, TEM and confocal microscopy studies. There
are likely multiple non-macropinocytotic mechanisms of endocytosis occurring for the
EGFR-targeted protocells. Here we have identified a primary caveolar route of
internalization with a small amount of clathrin mediated endocytosis for the zwitterionic
EGFR-targeted protocells, these pathways are depicted in Figure 3. The TEM of the A549
cell monolayers indicate the EGFR-targeted protocells are further trafficked to
multivesicular bodies and lamellar bodies in the cells which are noted in the literature to
be intracellular destinations for cargo internalized by a caveolar route in pulmonary cells.20,
24, 42-44, 106

The enhanced cellular uptake of EGFR-targeted MSNP2 rod shaped protocells

occurs by virtue of eliciting a cellular mechanosensory response with a more favorable
internalization due to what we correlate with previously published computational and
mathematical models72, 79 to be a function of the thermodynamics of the nanoparticle local
curvature at the initial contact area with the cell membrane. The tip of the rod shaped
EGFR-targeted protocells having a smaller initial contact area with the cell membrane
compared to the spherical shaped EGFR-targeted protocells allows for an increase in the
capacity for penetration at the cell plasma membrane as demonstrated by flow cytometry,
fluorescence plate reading and TEM of cell monolayers studies. The ability of the
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nanocarriers’ shape to influence the cellular uptake of mesoporous silica nanoparticles
functionalized with a peptide targeted supported lipid bilayer can now be seen as an
additional criterion to consider when creating targeted protocells for selective cellular
uptake. These findings also shed light on the mechanistic process by which cells are sensing
and internalizing differently shaped nanoparticles. The findings from this study will assist
in future efforts to refine the design of nanocarriers for their use in biomedical applications.
Methods and Materials
MSNP Synthesis
MSNP2, MSNP0 and MSNP EISA were synthesized using two different routes. Colloidal
synthesis was used to produce moderately polydispersed MSNP2 and MSNP0 as
previously reported.15 So-called evaporation induced self-assembly (EISA) using an
aerosol generator was used to produce the polydispersed spherical MSNP EISA as
previously described.11,
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Further details on MSNP synthesis can be found in the

supplemental information. Dye conjugation was performed on MSNP2, MSNP0 and
MSNP EISA that were post-aminated and resuspended in ethanol at 1 mg/mL by
attachment of either DyLight 488 – NHS (Thermo Fisher Scientific) or fluorescein
isothiocyanate, FITC, (Sigma Aldrich) in ethanol. To allow for consistency of particle
charge for cellular uptake and imaging studies including Cryo TEM, flow cytometry,
fluorescence plate reading, confocal microscopy and TEM of cell monolayers were all
carried out with either dye conjugated bare MSNP or dye conjugated MSNP cores in the
Non-targeted and EGFR-targeted protocells.
Protocells were formed by fusing 120-nm liposomes to the nanoporous core as reported
previously 11, 56, 91, and the composition of the SLB was optimized to reduce non-specific
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binding and to mitigate the cytotoxicity associated with cationic and, to a lesser extent,
anionic lipids. All lipids used to form protocells were purchased from Avanti Polar Lipids
except cholesterol was purchased from Sigma Aldrich.
Zwitterionic lipid formulations used in this study were the following: 60 wt% DOPC [1.5
mg/mL] (1,2-dioleoyl-sn-glycero-3-phosphocholine), 5 wt% DOPE [0.125 mg/mL] (1,2dioleoyl-sn-glycero-3-phosphoethanolamine), 5 wt% PEG-2000 PE [0.125 mg/mL] (1,2distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]),
and 30 wt% cholesterol [0.75 mg/mL] was used for the EGFR-targeted SLB with
rehydration in 0.5X PBS; 65 wt% DOPC [1.625 mg/mL], 5 wt% PEG-2000 PE [0.125
mg/mL], and 30 wt% cholesterol [0.75 mg/mL] was used for the non-targeted SLB w/PEG
2000 PE with rehydration in 0.5X PBS; 70 wt% DOPC [1.75 mg/mL], 30 wt% cholesterol
[0.75 mg/mL] was used for the non-targeted SLB w/out PEG with rehydration in 0.5X
PBS. The EGFR-targeted SLB with ~6 peptides formulation was 64.985 wt% DOPC [1.62
mg/mL], 0.015 wt% DOPE [0.00038 mg/mL], 5 wt% PEG-2000 PE [0.125 mg/mL], and
30 wt% cholesterol [0.75 mg/mL] and the EGFR-targeted SLB with ~120 peptides
formulation was 64.7 wt% DOPC [1.618 mg/mL], 0.3 wt% DOPE [0.0075 mg/mL], 5 wt%
PEG-2000 PE [0.125 mg/mL], and 30 wt% cholesterol [0.75 mg/mL], as described
previously.56 The free primary amine group on the dioleoyl phosphatidylethanolamine
served to react with the NHS end of the SM(PEG)24 (Thermo Fisher Scientific/Pierce,
Product #22114) heterobifunctional structure with the maleimide portion of the
SM(PEG)24 crosslinker binding to the end of the terminal cysteine located on the GE 11
peptide, containing a PEG (n=4) spacer with the amino acid sequence (H2NYHWYGYTPQNVI(dPEG4)C-OH) synthesized by New England Peptide (Gardner, MA),
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to form the sulfhydryl group leading to the crosslinking of the GE 11 targeting moiety to
the SLB, creating the EGFR-targeted SLB on the EGFR-targeted protocells. The
SM(PEG)24 crosslinker was incubated with the EGFR-targeted SLB fused on the MSNP
at room temperature and then centrifuged at 4000 rpm at 4°C for 10 minutes and resuspended in 0.5X PBS. The GE 11 targeting peptide was then incubated with the EGFRtargeted SLB fused on the MSNP. Then the GE 11 (EGFR) targeted MSNP protocells were
centrifuged for 10 minutes at 4000 rpm at 4°C, using either an Eppendorf centrifuge model
5424 with rotor #SA452411 or a Eppendorf 5417R with rotor #A-8-11. Note prior to GE
11 peptide incubation the GE 11 peptide was dissolved in molecular grade water at a
concentration of 1 mg/mL and reduced using TCEP (Tris (2-carboxyethyl) phosphine
hydrochloride, Sigma Aldrich)) dissolved in molecular grade water immediately before use
and added to the GE 11 peptide to give a final concentration of 5 mM and then incubated
at room temperature for 30 minutes before conjugation.
DLS and Zeta Potential
The mean diameters of the particles were determined by dynamic light scattering (DLS)
using a Malvern Zetasizer Nano-ZS equipped with a He-Ne laser (633 nm) and NonInvasive Backscatter optics (NIBS). The samples for dynamic light scattering (DLS)
measurements were suspended in various media (molecular grade H2O, 0.5X PBS, RPMI,
and RPMI+10% FBS(CRPMI)) at ~125 µg/mL. All the hydrodynamic size and zeta
potential measurements were carried out at 25 °C on the Malvern Zetasizer Nano-ZS. DLS
measurements for each sample were obtained in triplicate. The hydrodynamic size of all
samples was reported using a z-average diameter. The zeta potential readings of the bare
MSNP without amination and with no dye or FBS coating, bare MSNP with amination no
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dye no FBS coating, bare MSNP with dye with FBS coating, non-targeted protocells (with
PEG 2000PE) and EGFR-targeted protocells were taken in either 0.5 X Phosphate Buffered
Saline (PBS) (pH=7.4), molecular grade H2O or CRMPI. To reduce nanoparticle
agglomeration before bio-functionalizing and incubation with cells the bare MSNP were
resuspended in 0.5X PBS (pH=7.4) with probe sonication at a 20% amplitude for 15 second
durations and the EGFR-targeted and Non-targeted protocells were sonicated for 10
minutes in a water bath sonicator. To reduce nanoparticle agglomeration before incubation
with cells for the inhibition studies, the dye conjugated bare MSNP2, MSNP0 and MSNP
EISA were dispersed by sonication with a QSonica probe sonicator of the stock solutions
in ethanol for 15 s before being aliquoted, centrifuged at 14,000 g for 10 minutes with 5
subsequent water washes and centrifugation at 14,000 g for 10 minutes and resuspension
in water with 5% FBS to coat the surface of the MSNP to give a concentration of 1 mg/mL
followed by sonication for 15 s before use.
XRD, Cryo TEM, TEM
X-ray diffraction data was obtained using a PANalytical X’Pert Pro system equipped with
an X’Celerator strip detector and Cu Kα source. Preparation of vitrified TEM samples was
through the use of a FEI Vitrobot, using a blot time of 4.5 seconds, blot force of 1, drain
time of 1 second, applied volume of sample (at ~ 2 mg/ml concentration, in PBS) = 3 µL,
and Cu QUANTIFOILTM R 2/1 holey carbon grid substrates. TEM was performed on a
JEOL 2010 operating at 200 kV in under-focus conditions, using a GATAN Model 626
Single Tilt Liquid Nitrogen Cryo Transfer Holder. Regular TEM was performed on a JEOL
2010 operating at 200 kV or a JEM 1200 EX operating at 80 kV. Samples for TEM imaging
were obtained by placing a drop of the respective MSNP onto either 200 mesh formvar
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coated grids, holy carbon grids or 200 mesh copper TEM grids with drying at room
temperature. The aspect ratios were obtained by measuring the Cryo TEM for the length
and diameter of at least 30 randomly selected particles.
Cell Culture
A549 (ATCC CCL-185) human lung carcinoma (used at passages 23-47) and MRC9
(ATCC CCL-212) human lung fibroblast cells (used at passages 15-32) from American
Type Culture Collection (Manassas, VA) were maintained in F-12K medium (CORNING
Cellgro, VA) containing 10% fetal bovine serum (FBS) (Thermo Fisher Scientific) with
1% penicillin and streptomyosin (Thermo Fisher Scientific) and high glucose Dulbecco's
Modified Eagle Medium (DMEM) (CORNING Cellgro, VA) containing 10% fetal bovine
serum (FBS) and 1% penicillin and streptomyosin at 37°C and 5% CO2.
Flow Cytometry - Nanoparticle Cellular Uptake and Inhibition studies.
Flow cytometry was used to compare the cellular uptake of the Bare MSNP to MSNP
prepared as: Non-targeted with PEG 2000 PE SLB, Non-targeted without PEG 2000 PE
SLB, or EGFR-targeted SLB. To reduce nanoparticle agglomeration before incubation
with cells for the inhibition studies the dye conjugated bare MSNP2, MSNP0 and MSNP
EISA were dispersed by QSonica probe sonication of the stock solutions in ethanol for 15
s before being aliquoted, centrifuged at 14,000 g for 10 minutes with 5 subsequent water
washes and centrifugation at 14,000 g for 10 minutes and resuspension in water with 5%
FBS to coat the surface of the MSNP to give a concentration of 1 mg/mL followed by
sonication for 15 s before use and the Non-targeted with PEG 2000 PE, Non-targeted
without PEG 2000 PE, EGFR-targeted protocells were bath sonicated for 10 minutes before
use. Flow cytometry was performed on A549 cells that were grown to 70% confluency in
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Corning Costar cell culture 12-well plates, incubated with 20 µg of Bare MSNP, Nontargeted with PEG 2000PE, Non-targeted without PEG 2000 PE, or EGFR-targeted
protocells for 2 hours at 37°C, 5% CO2, washed 5 times with PBS, trypsinized, washed
with PBS, fixed with 3.7% paraformaldehyde, washed 3X with PBS, and re-suspended in
1 ml of PBS. The inhibition of cellular uptake study was performed with A549 cells that
were grown to 70% confluency in Corning Costar cell culture 12-well plates incubated
with 20 µg/mL of bare MSNP or EGFR-targeted protocells for 2 hours at 37°C, 5% CO2,
with and without inhibition, washed 5 times with PBS, trypsinized, washed with PBS, fixed
with 3.7% paraformaldehyde, washed 3X with PBS, and re-suspended in 1 ml of PBS.
Mean fluorescence intensity on FL1 channel was collected for 3,455-18,750 cell events
using a BD Biosciences LSR Fortessa flow cytometer at the University of New Mexico
(UNM) Shared Flow Cytometry and High Throughput Screening Resource Center with the
number of positive events collected to give a coefficient of variation of 5% or less for each
run with each sample type having at least an n=3. The inhibition experiments were
performed by A549 cell media 2 hour pre-treatment and co-treatment to allow for cells to
be inhibited before treatment and during treatment with nanoparticles with the following
inhibitors and their respective mechanism of action: 1) excess free EGFR (GE 11)-targeting
peptide (150 µg/mL): competitive EGFR binding to block EGFR-targeted protocells from
binding; 2) PD153035 (10 nM) (EGFR activation inhibitor/ EGFR inhibitor): that blocks
EGFR tyrosine kinase activity; 3) LDV (1 µM): specifically inhibits ligand binding to
integrin dimer α4β1; 4) monodansylcadaverine (dansyl) (50 µM): inhibits formation of
clathrin-coated pits and transglutaminase; 5) amiloride (75 µM): interferes in
macropinocytosis by inhibiting Na+/H+ exchange; 6) nocodazole (10 µg/mL) : disrupts
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microtubule (cytoskeleton); 7) cytochalasin D (cytoD) (5 µg/mL): inhibits F-actin
polymerization (cytoskeleton); 8) methyl-beta-cyclodextrin (MBCD) (5 mg/mL):
cholesterol-depletion reagent (caveolae/lipid rafts inhibitor); or 9) 4°C incubation
temperature: prevents energy dependent cell function. Data are reported as % cellular
uptake of the mean fluorescence intensity (MFI), using Bare MSNP2 or EGFR-targeted
MSNP2 uptake as reference.
Plate Reading - Binding Characterizations of the EGFR-targeting GE 11 Peptide on
the SLB on the MSNP.
Apparent binding affinity (Kd) values of EGFR-targeted protocells with MSNP0, MSNP2
and MSNP EISA cores were determined by the following procedure A549 or MRC9 cells
were seeded at a density of 10,000 cells/well in a 96 well black solid bottom plate (Corning
Costar) for use the next day. Cells were incubated with different concentrations of EGFRtargeted protocells and non-targeted protocells (10, 30, 100, 300, 1000 and 3000
µgrams/mL, the number of particles/mL for the different concentrations is shown in
Supplemental Table S4) for 1 hour on ice, and then gently washed with ice-cold PBS 5X.
The FL1 (Dylight 488 in silica) was measured for each well of cells covered with a 100
µliters of ice cold PBS. Measurements were taken using a Wallac 1420-040 Victor 3V
multilabel plate reader in the UNM Shared Flow Cytometry and High Throughput
Screening Resource Center. The Kd for the binding curves were determined using
GraphPad Prism (GraphPad Software, Inc.; La Jolla, CA).
Confocal Fluorescence Microscopy – Bare MSNP, Non-targeted and EGFR-targeted
Protocell Binding and Internalization
Confocal microscopy performed to obtain filopodia counts per cell were run as follows:
the A549 cells were grown to ~70% confluency in Nunc 4-well slides (Thermo Fisher
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Scientific), incubated with 20 µg/mL of either bare MSNP, non-targeted protocells, EGFRtargeted protocells for 2 hours at 37°C and 5% CO2. The cells were then washed 4X in PBS
(pH = 7.4), fixed with paraformaldehyde, quenched with 50 mM ammonium chloride in
PBS for 10 minutes, washed 3X with PBS, permeabilized with 0.1% Triton X100 in 0.2%
fish skin gelatin (Sigma Aldrich). Afterwards the cells were washed three times with PBS
and stained with Alexa Fluor 633 Phalloidin, washed with PBS (pH = 7.4), and mounted
with Slow Fade DAPI with confocal images taken on a Zeiss 510 META confocal
microscope with a 63X oil immersion objective at the UNM Fluorescence Microscopy
Shared Resource Facility.
The confocal experiment with the bare MSNP2 with inhibitors was carried out on A549
cells grown to ~70% confluency on Nunc 4-well glass slides (Thermo Fisher Scientific).
The cells were incubated with the following inhibitors with respective concentrations:
amiloride [75 µM], cytochalasin D (Cyto D) [5 µg/mL]; methyl-beta-cyclodextrin
(MBCD) [5 mg/mL], for 2 hours pre-treatment at 37°C and 5% CO2. The cell media was
then replaced by fresh complete media with 20 µg/mL of bare Dylight 488 MSNP2 with
or without inhibitors (inhibitors used at the same concentrations as pre-treatment) for 2
hours at 37°C and 5% CO2. After incubation the cells were washed 4X with PBS (pH =
7.4), fixed with ~3.7% paraformaldehyde, quenched with 50 mM ammonium chloride in
PBS for 10 minutes, washed 3X with PBS, permeabilized with 0.1% Triton X100 in 0.2%
fish skin gelatin. After washing the cells 3X with PBS the cells were stained with Alexa
Fluor 555 Phalloidin (Thermofisher Scientifc), washed with PBS (pH = 7.4), and mounted
with Slow Fade DAPI and Z-stack images of the fixed cell samples were taken for the
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sample groups on a Leica TCS SP8 confocal microscope with a 63X oil immersion
objective at the UNM Fluorescence Microscopy Shared Resource Facility.
The confocal microscopy binding and internalization on A549 and MRC9 cells was
performed as follows: A549 and MRC9 cells were grown to ~70% confluency on Nunc 4well glass slides (Thermo Fisher Scientific). The confocal microscopy studies of EGFRtargeted MSNP2 with different numbers of peptides (~6 peptides, ~120 peptides and ~2048
peptides) were added at a concentration of 50 µg/mL of media to A549 cells on ice for one
hour. For the binding and internalization confocal fluorescence microscopy experiment
A549 and MRC9 cells were incubated for ~2 hours at 37°C with 5% CO2 with 50 µg/mL
with the following nanoparticles: Bare MSNP, non-targeted protocells with PEG2000 PE
or EGFR-targeted protocells. After incubation in both experiments, the media on the cells
was removed and replaced with 500 µl of media containing Invitrogen’s CellMask™
orange plasma membrane stain and incubated for 5 min @ 37⁰C in the incubator with 5%
CO2. The media was then removed and cells were gently washed 5X with PBS (pH=7.4),
formaldehyde fixed for 10 minutes and washed 3X with PBS (pH=7.4). Alternatively, the
cells were stained with Alexa Flour 633 Phalloidin with the same method as previously
described. The coverslips were mounted to the Thermo Fisher Scientific 4-well Nunc slides
with Slow Fade Gold with DAPI (nuclear stain) and edges were sealed with nail polish.
The images of a mid-slice of the cells for the different groups were taken on a Zeiss 510
META confocal microscope with a 63X oil immersion objective or a Leica TCS SP8
confocal microscope with a 63X oil immersion objective at the UNM Fluorescence
Microscopy Shared Resource Facility.
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EGFR-targeted Protocell Early Endosome, Clathrin or Caveolin 1 Colocalization
The A549 cells were incubated at 37°C and 5% CO2 with each of the following
nanoparticles at 50 µg/mL in media (number of nanoparticles/mL for each EGFR-targeted
MSNP is listed in parenthesis and listed in Supplemental Table S4): EGFR-targeted
MSNP2 protocells (at ~2.81 x 10^10 nanoparticles/mL), EGFR-targeted MSNP0
protocells (at ~6.28 x 10^10 nanoparticles/mL) or EGFR-targeted MSNP EISA protocells
(at ~5.05 x 10^10 nanoparticles/mL) with the incubation time as indicated for the different
colocalization studies as follows: 45 minutes for the early endosome, 20 minutes for the
clathrin and 1 hour for the Caveolin 1. After incubation cells were gently washed 5X with
PBS, fixed with 3.7% paraformaldehyde, washed 3X with PBS, quenched with 50 mM
ammonium chloride in PBS for 10 minutes, washed 3X with PBS, and permeabilized with
0.1% Triton X-100 in 0.2% fish skin gelatin and washed 3X with PBS. The following
primary monoclonal antibodies from Cell Signaling Technology were incubated at a 1:100
dilution in 0.2% FSG/PBS for one hour at room temperature: for early endosome staining
the early endosome antigen (EEA1 (C45B10) Rabbit mAb) was used; for clathrin coated
pits staining the clathrin heavy chain (Clathrin Heavy chain (D3C6) XP Rabbit mAb) was
used; for caveolin 1 staining the caveolin 1 (Caveolin-1 (D46G3) XP® Rabbit mAb #3267)
was used. The cells were then washed 3X with PBS. The cells were then incubated further
with a secondary antibody (Anti-rabbit IgG (H+L), F(ab') 2 Fragment (Alexa Fluor 555
Conjugate)) from Cell Signaling Technologies at a dilution of 1:1000 for 1 hour at room
temperature, washed 3X with PBS, mounted with Slow Fade DAPI and a coverslip was
placed on top of the cells on the Thermo Fisher Scientific 4-well. Z-stack images of the
fixed cell samples were taken for the sample groups on a Leica TCS SP8 confocal
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microscope with a 63X oil immersion objective at the UNM Fluorescence Microscopy
Shared Resource Facility. Quantitative analysis of the Z-stack confocal images for
colocalization between either early endosome antigen protein (EEA1), clathrin coated pits
(clathrin) or caveolin 1 and nanoparticles was performed using Slidebook 6 software
(Intelligent Imaging Innovations, Inc.; Philadelphia, PA) and the results reported as %
colocalization of the green pixels of the EGFR-targeted protocell with the red pixels of
either the EEA1, clathrin or caveolin 1 was reported.
TEM
TEM of cell monolayers was used to obtain images of nanoparticles binding and
internalizing on the A549 cells. A549 cells were grown to ~70% confluency on Nunc
Thermanox plastic coverslips (Thermo Fisher Scientific) or EMS glass coverslips (VWR)
in 6-well cell culture plates (Corning Costar). The A549 cells were then incubated for 3
hours at 37°C and 5% CO2 with the following: 50 µg/mL of Bare MSNP2 or Bare MSNP0;
300 µg/mL of EGFR-targeted MSNP2 or MSNP0; 150 µg/mL of EGFR-targeted MSNP
HP or EGFR-targeted MSNP LP. Adherent A549 cells were washed 3 times in 1X PBS,
then fixed overnight at 4°C in 2.5% glutaraldehyde in 1X PBS. They were then washed
three times in 1X PBS followed by fixation with reduced osmium tetroxide for one hour at
room temperature. The cells were washed with H2O, dehydrated with a graded acetone
series, then embedded in Spurr's resin. En face sectioning yielded 70 nm thin sections that
were stained with 2% uranyl acetate and Reynold's lead citrate. Imaging was performed
on a Hitachi H7500 TEM equipped with an AMT XR60 bottom mount camera. In addition,
EGFR-targeted MSNP2 protocell samples were also prepared by pelleting. Pelleted cells
were washed 3 times in 1X PBS, then fixed overnight at 4 C in 2.5% glutaraldehyde in 1X
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PBS. They were removed from plates by scraping, pelleted and washed with 1X PBS, then
fixed with reduced osmium tetroxide for one hour at room temperature. The cells were
washed with DI water, dehydrated with a graded acetone series, then embedded in Spurr's
resin. Thin sectioning yielded 70 nm thin sections that were stained with 2% uranyl acetate
and Reynold's lead citrate. Imaging was performed on a Hitachi H7500 TEM equipped
with an AMT XR60 bottom mount camera.
Statistical Analysis
Data represent the mean ±SD for the DLS and Zeta measurements in triplicate and TEM
particle measurements, n≥30 and TEM particle measurements, n=185. Data represent the
mean ± 95% confidence intervals for the apparent binding affinities. Data represent the
mean ± SEM for the other experiments in triplicate or duplicate measurements. Differences
between the cellular uptake of nanoparticles were analyzed by a two sided student’s t test.
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Chapter 3
Discussion and Conclusion
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Discussion

This dissertation focuses on utilizing the shape of MSNP and surface chemistry
functionalization to allow for greater enhancement of selective targeting of non-small cell
lung cancer cells, A549 cells. It has previously been demonstrated in a recent investigation
employing an engineered library of bare MSNP with the same surface chemistries and
similar diameters (~80 nm) but with varying aspect ratios from ~1 (spherical) to 3 (rod)
where the shape of the MSNP alters the cellular uptake in HeLa and A549 cells.
Specifically this research found that rod-shaped MSNP with AR ~ 2.1-2.5 had an
appreciably larger amount of cellular uptake in HeLa and A549 cancer cells compared to
the spherical MSNP with smaller AR or rods with larger AR by a non-specific
macropinocytosis route of cellular internalization.15 However, a limitation of the study was
that the bare MSNP are taken up by the cell in a non-specific manner that has been shown
to allow their internalization into healthy as well as cancerous cells.56 Another study was
carried out to redirect the non-specific cellular uptake of the bare MSNP in Hep3B,
hepatocellular carcinoma cells and healthy human hepatocytes to a more selective cellular
uptake by the fusion of a supported lipid bilayer with a SP94 targeting peptide, a
hepatocellular carcinoma peptide with 10,000 fold greater affinity to Hep3B cells versus
human hepatocytes. The construct was coined a ‘protocell’.56 The addition of the SP94targeted SLB onto the MSNP led to a change in the non-specific cellular uptake of bare
MSNP in healthy human hepatocytes and human hepatocellular carcinoma Hep3B cells to
a selective cellular internalization into Hep3B cells over human hepatocytes.56
However, the influence of aspect ratio and shape in combination with the ‘protocell’
concept has not been elucidated. This dissertation research aimed to gain a better
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understanding of the role aspect ratio and shape would play together with the concept of
the “protocell” in cellular internalization of MSNP. The first aim was to determine if the
fusion of a supported lipid bilayer coating would abrogate the non-specific
macropinocytosis of the bare MSNP in A549 and MRC9 cells. The second aim was to find
out if there would be a shape enhancement of selective cellular internalization in A549
cells of the rod shaped bare MSNP2, AR~1.8-2.3, versus spherical shaped bare MSNP0,
AR~1-1.2, and highly polydispersed spherical shaped bare MSNP EISA, AR~1, by virtue
of fusing a GE 11 targeted supported lipid bilayer to the MSNP.
The first aim of this research was to determine if a conformal supported lipid bilayer
coating on the surface of the MSNP would reduce the level of cellular uptake in A549,
non-small cell lung cancer cells and MRC9, healthy lung fibroblast cells. It was found by
cryo TEM that functionalization by fusion of a zwitterionic supported lipid bilayer
approximately 4 nm thick to the bare dye conjugated MSNP allows for conservation of the
shape and size of the MSNP. Furthermore, the addition of the zwitterionic supported lipid
bilayer leads to a conformal encasement of the MSNP rendering it unrecognizable by the
cell’s active sensory system due to masking of the MSNP surface silanols Si-OH and
deprotonated silanols Si-O-, known to interact with cell membranes via hydrogen bonding
and electrostatic interactions, respectively. 11, 15, 56, 90-93 The masking of the MSNP surface
silanols Si-OH and deprotonated silanols Si-O- with the supported lipid bilayer was
shown by flow cytometry, confocal microscopy and TEM of cell monolayers to greatly
decrease the non-specific, shape-stimulated macropinocytotic pathway for A549, nonsmall cell lung (NSCLC) cells. Taken together, these results support the idea that the cell
sensory system is influenced by non-covalent electrostatic and hydrogen bonding
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interactions between the silanols (and amines) on the MSNP surface with the biomolecular
elements of the cell membrane.
The second aim of this research was to establish if it would be possible to alter the surface
chemistry of the rod and spherical shaped MSNP by addition of an EGFR-targeted SLB
and allow for a shape enhanced internalization pathway for selective uptake into A549 lung
cancer cells over the healthy MRC9 cells. To achieve this aim we selected an EGFR
targeting ligand, GE 11, with an amino acid sequence, YHWYGYTPQNVI, to conjugate
to the surface of the SLB coating the MSNP to support selective binding to EGFR, which
is highly overexpressed on the lung cancer A549 cells in comparison to the healthy lung
MRC9 cells.75-78,

112-119

The outcomes from the flow cytometry, confocal fluorescence

microscopy and TEM of cell monolayers indicate that A549 cells endocytose EGFRtargeted rod-shaped and EGFR-targeted spherical-shaped protocells by a process different
and more selective than the macropinocytosis route of the Bare MSNP by fusion of an SLB
with the GE 11 (EGFR) targeting peptide to the bare MSNP. We show the bare MSNP are
mainly taken up by the macropinocytosis route with the more monodispersed bare spherical
MSNP0 using a clathrin mediated process to a smaller extent. It was shown that the bare
rod shaped MSNP2 with a higher aspect ratio of ~1.8-2.3 allowed for an increase in cellular
uptake versus the spherical shaped MSNP0 and MSNP EISA with aspect ratios of ~1-1.2
in the A549 cells treated with the different nanoparticles when comparing the MFI. It was
found that an increase in polydispersity of the spherical bare and EGFR-targeted MSNP
EISA led to a reduction in cellular uptake in comparison to the respective bare and EGFRtargeted spherical MSNP0.
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We demonstrated a strong shape enhanced cellular uptake for the EGFR-targeted rod
shaped MSNP2 protocell with AR ~1.8-2.3 in comparison to the spherical shaped MSNP0
and MSNP EISA EGFR-targeted protocells. The mechanism of cellular internalization of
the EGFR-targeted protocells was determined to be mediated by the initial step of binding
of the EGFR-targeted protocell through recognition of the EGFR targeting peptide (GE 11
peptide) by the cell membrane with high affinity for the EGFR and without EGFR
activation. The further internalization of the EGFR-targeted protocells was followed by a
caveolin 1 mediated process of endocytosis for all three EGFR-targeted protocell types.
Further trafficking of the EGFR-targeted protocells taken up by a GE 11 targeting peptidemediated process was found to go to the early endosome compartments, multivesicular
bodies and lamellar bodies of the A549 cells.
Interestingly, a more recent study was conducted to determine if the shape and size of
anionic hydrogel nanoparticles with volume, charge and material composition remaining
constant would alter the cellular uptake of the nanoparticles in epithelial, endothelial and
immune cells.8 In this study nanodiscs and nanorods of different sizes composed of
polyethylene glycol diacrylate (PEGDA)-based hydrogel prepared by a Jet and Flash
Imprint Lithography technique as well as polystyrene nanospheres were used. The zeta
potential of the nanoparticles were all about -57 mV. The sizes of the nanoparticles were
discoidal (220 nm diameter (d) × 100-nm height (h); 325 nm d × 100-nm height (h) and 80
nm d × 70 nm height (h)); cuboidal (rod-shaped) nanoparticles (100 × 100 × 400 nm and
100 × 100 × 800 nm) and spherical polystyrene nanoparticles (nanospheres) (100 nm
diameter and 200 nm diameter).8
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The results from the study using flow cytometry, chemical inhibition and confocal
microscopy techniques indicated that mechanisms of cellular internalization changed based
on cell type. It was also found that all cell types showed a difference in cellular uptake of
nanoparticles with respect to nanoparticle shape and size, which correlates to our finding
that shape impacts on cellular uptake of nanoparticles.8 In HUVEC endothelial cells the
intermediary sized discs (220 nm) were taken up in more abundance when compared to the
larger and smaller volumes and nanorods. However the cell uptake of the nanodiscs was
shown to go up with increasing size of the nanoparticles and more than the nanorods in
both the immune cells, BMDCs and the Hek293 cancerous kidney epithelial cells.8
Furthermore it was found that the HeLa cells used caveolae-mediated endocytosis for both
the discs and rods.8 Our findings in the research here are in line with the findings that
different shaped particles can use the same mechanism of internalization such as the
caveolae-mediated endocytosis of the EGFR-targeted rod and spherical protocells.8 In
contrast to our findings macropinocytosis was also found to be part of the mechanism of
cellular uptake by inhibition with amiloride in all the cell lines, indicating that non-specific
uptake was occurring for the nanoparticles.8 This research suggests that cellular
mechanisms of internalization of nanoparticles is influenced by the size and shape of the
nanoparticles. The explanation for the differences of cell uptake due to size and shape
changes was attributed to three main aspects, which were the interaction of the nanoparticle
at the surface of the cell plasma membrane, the degree of adhesion between the nano-bio
interface and the required strain energy for membrane wrapping.8
One of the limitations of this dissertation research is the scope of the nanoparticle shapes
and sizes used. Future studies to further unravel the shape and size influence on cellular
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uptake in A549 cells will assist in determining if using a disc shaped over a rod shaped
nanoparticle with intermediary size, AR~2 would result in an even greater cellular uptake
of the EGFR-targeted protocells or whether additional targeted SLB fused onto MSNP
could allow for an even greater enhancement in cellular uptake of targeted protocells into
target cells.
Conclusion

In this dissertation research we have clearly shown that the introduction of an EGFR
targeting peptide (GE11) to the SLB fused onto bare MSNP, allows the A549 cell to
selectively recognize the EGFR-targeted protocells and diminish the non-specific
macropinocytosis of the bare MSNP. The outcomes highlight a two-step mechanism of
cellular internalization for the EGFR targeted protocell which is more selective compared
to the bare MSNP.
The first step involves the functionalization of the GE11 (EGFR) targeting peptide on the
protocell which provides a means for the A549 cells to specifically recognize the EGFRtargeted protocell as indicated by the plate reading apparent effective binding experiment
and flow cytometry competitive binding experiment with excess free GE 11 peptide
leading to a strong reduction in cellular uptake of the EGFR-targeted protocells but not
altering the cellular uptake of the bare MSNP. Furthermore the flow cytometry data showed
a strong increase in cellular uptake of EGFR-targeted protocells compared to non-targeted
protocells. This research provides a way to selectively target A549 cells without eliciting
negative mitogenic signaling by using the EGFR-targeting peptide GE 11 on the SLB of
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the protocells, which is indicated by a lack of requiring EGFR activation, supported by
chemical inhibition studies.
The second step of the EGFR-targeted protocell internalization once the EGFR (GE11)targeted protocell is recognized by the A549 cells involves interaction with the plasma
membrane and the cellular endocytic machinery to allow for cellular internalization,
indicated by results from flow cytometry, chemical inhibition studies, confocal
fluorescence microscopy and TEM of cell monolayers. The cellular machinery of the A549
cell responds to the EGFR-targeted protocell with a greater cellular uptake due to the
sharper angle of approach for the rod shaped EGFR-targeted protocells to the plasma
membrane compared to the spherical shaped EGFR-targeted protocells, shown by flow
cytometry and TEM of cell monolayers and supported by previously reported
computational and mathematical modeling.72, 79
The rod shaped MSNP2 EGFR-targeted protocells get endocytosed mainly by a caveolin
1 dependent pathway and a small amount of clathrin-dependent pathway, supported by
flow cytometry and confocal microscopy studies, to a greater degree than the spherical
EGFR-targeted protocells with both being shuttled to the early endosome. This occurs by
virtue of eliciting a cellular mechanosensory response with more favorable internalization
due to ligand receptor binding and the thermodynamics (energy requirement for particle
penetration and membrane wrapping) of the nanoparticle curvature upon approach at the
membrane demonstrated by fluorescence plate reading, TEM and TEM of cell monolayers
studies as well as previously reported computational and mathematical modeling.72, 79
Importantly we clearly show a selective EGFR-mediated predominantly caveolin 1
dependent pathway that exhibits a strong shape dependence, with EGFR-targeted MSNP2
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rods with intermediate aspect ratios having a significantly higher internalization efficiency
than moderately dispersed or polydispersed spherical MSNP with lower aspect ratios in
A549 cells. The research herein demonstrates the shape of the nanocarriers influence
cellular uptake of mesoporous silica nanoparticles functionalized with a peptide targeted
supported lipid bilayer. Therefore, the shape of mesoporous silica nanoparticles can now
be added as an additional criteria to consider when creating targeted nanoparticles for
selective cellular uptake. These outcomes also elucidate on the mechanistic process by
which cells are sensing and internalizing different shaped peptide targeted nanoparticles.
The findings from this study will assist in future efforts to refine the design of nanocarriers
for their use in biomedical applications.
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APPENDIX A: Supplemental Material
MSNP Synthesis
The MSNP0 and MSNP2 were chemically synthesized by a colloidal sol-gel approach
using a surfactant CTAB, cetyltrimethylammonium bromide (Sigma-Aldrich), and costructure directing agent PFOA, perfluorooctanoic acid (Sigma-Aldrich), mixture as
template. The differently shaped MSNP0 and MNSP2 with differing ARs were synthesized
by varying the PFOA/CTAB molar ratio as follows: MSNP0 = 0 and MSNP2 = 0.03. The
PFOA/CTAB mixture was stirred at 600 rpm for 1 h at room temperature before the
addition of 2.1 mL of 2 M NaOH. Subsequently, the solution temperature was increased to
80°C before the addition of 4.1 mL of TEOS, tetraethyl orthosilicate (Sigma-Aldrich). This
mixture was stirred for an additional 2 h, and the precipitate was carefully collected by
filtration. After washing three times with methanol (Thermo Fisher Scientific) and
deionized water, the solids were air-dried overnight at room temperature. The MSNP
templates were removed by extracting the CTAB with HCl (Hydrochloric acid (36.5-38%,
HCl), EMD Chemicals (Gibbstown, NJ)), containing methanol under nitrogen protection.
The resulting MSNPs were collected by filtration, washed with methanol, and dried
overnight in air. To visualize the particles under a confocal microscope or perform flow
cytometry, MSNPs were prepared by suspending 200 mg of MSNP in 10 mL of dry toluene
(Thermo Fisher Scientific) with 3 µL of APTES (Gelest), 1-10 mg/mL. The particles were
further conjugated at 1 mg/mL in ethanol with either DyLight 488 – NHS (Thermo Fisher
Scientific) or fluorescein isothiocyanate, FITC, (Sigma Aldrich) in ethanol (PharmacoAAPER). The dye labeled MSNPs were collected by centrifugation and washed with
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ethanol (Pharmaco-AAPER) and then washed 5X with molecular grade water (SigmaAldrich) before use.
MSNP EISA were synthesized from a homogenous mixture of water-soluble silica
precursor(s) and amphipathic surfactant(s) using the aerosol-assisted evaporation-induced
self-assembly (EISA) method as previously described in the literature.11, 56 Briefly, the
silica/surfactant aerosols were made using a commercial atomizer (Model 9302A, TSI,
Inc., St Paul, MN) and nitrogen as a carrier/atomization gas. The initial reaction began with
a homogeneous solution of soluble silica precursor, TEOS (Sigma Aldrich) and HCl (EMD
Chemicals), and surfactant prepared in an ethanol (Pharmaco-AAPER)/water solution with
an initial surfactant concentration c0 much less than the critical micelle concentration,
c.m.c. The temperature for the heating zones was kept at 400°C. Particles were collected
on a Durapore Membrane Filter maintained at 80°C. CTAB was selected as the structure
directing template. The MSNP EISA templates were removed by extracting the CTAB by
calcination at 550°C for 6 hours. The particles were collected by centrifugation, washed
twice in ethanol followed by particle drying in a vacuum oven at room temperature. Next,
the particles were prepared by suspending 50 mg of MSNP in 96.77 mL of ethanol followed
with sonication. Next 3.23 mL of APTES (Sigma Aldrich) is added to the particle solution
with stirring and 250 µl of DI water is added. The particle-APTES solution is stirred for 6
hours. After 6 hours the particle solution is centrifuged and washed with 200 proof ethanol
3 times. After washing the MSNP EISA are suspended in 200 proof ethanol at 1 mg/mL.
Lastly the MSNP EISA were resuspended in 200 proof ethanol at 1 mg/mL followed with
dye conjugated of DyLight 488 – NHS (Thermo Fisher Scientific) in ethanol.
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MSNP HP was synthesized by a colloidal method and MSNP LP were synthesized by a bi
phase method as described in the literature.52, 120-125 Synthesis of MSNP HP hexagonal
prism shaped MSNP was carried out as previously reported in the literature.120 FITC
attachment to the MSNP HP and MSNP LP was performed during synthesis.
MSNP HP was synthesized by a colloidal method and MSNP LP were synthesized by a bi
phase method.52, 120-125 Synthesis of MSNP HP hexagonal prism shaped MSNP was carried
out as previously reported in the literature.120 To prepare the dye-labeled MSNP HP, 1.1
mg of fluorescein isothiocyanate (FITC, Sigma Aldrich, St. Louis, MO) was dissolved in
N,N-dimethyl formamide, DMF (Sigma Aldrich, St. Louis, MO) followed by addition of
1.5 µL of 3-aminopropyltriethoxysilane (APTES, Sigma-Aldrich, St. Louis, MO). 121 The
FITC–APTES solution was incubated at room temperature for at least 1 hour before
addition to the surfactant solution. The surfactant solution was prepared by dissolving 0.8
mM of cetyltrimethylammonium bromide (CTAB, Sigma-Aldrich, St. Louis, MO) in 150
mL of 510 mM ammonium hydroxide solution (Sigma-Aldrich, St. Louis, MO) in a 250
mL beaker, sealed with parafilm (Neenah, WI) and heated to 50 °C. After continuously
stirring for 1 hour, 3 mL of 0.88 M TEOS (Sigma-Aldrich, St. Louis, MO) solution
prepared in ethanol (PHARMCO-AAPER, Brookfield, CT) and 1 mL of FITC-APTES
solution were combined and added immediately to the surfactant solution with an
additional 1 hour of stirring. The particle solution was stored at 50°C for ~18 hours at static
conditions. The particle solution was then sealed in a medium bottle and heated at 70 °C
for 24 hours. CTAB removal was performed by transferring the as-synthesized particles to
a 75 mM ammonium nitrate (Sigma-Aldrich, St. Louis, MO) ethanolic solution and set in
an oil bath at 60°C for 1 hour with reflux and stirring, as previously described in the
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literature.120 The particles were then washed in 95% ethanol and transferred to 12 mM
hydrochloric acid ethanolic solution (36.5-38% HCl, EMD Chemicals, Gibbstown, NJ))
and heated at 60 °C for 2 hours with reflux and stirring. Then particles were further washed
in 95% ethanol, then 99.5% ethanol, and stored in 99.5% ethanol.
The synthesis of the MSNP LP was performed with a biphase method, as previously
published.121-123 The synthesis of MSNP LP (9 nm pore size) were prepared with the
modified conditions as performed by Shen et al.123 To prepare the MSNP LP, 0.18 g of
triethanolamine (TEA, Sigma Aldrich, St. Louis, MO) was weighed in a 100 mL round
bottom flask. Then 36 mL of DI water and 24 mL of 25 w% cationic
cetyltrimethylammonium chloride (CTAC, Sigma Aldrich, St. Louis, MO) were added to
the round bottom flask. The mixture solution was stirred at 300 rpm and heated at 50°C.
To prepare the dye-labeled MSNP LP, 1.5 mg of fluorescein isothiocyanate (FITC, Sigma
Aldrich, St. Louis, MO) was dissolved in N,N-dimethyl formamide, DMF (Sigma Aldrich,
St. Louis, MO) followed by addition of 1.5 µL of 3-aminopropyltriethoxysilane (APTES,
Sigma-Aldrich, St. Louis, MO) and incubated for 1 hour before addition to surfactant
solution.121 After 1 hour, the FITC/APTES solution was added followed by slow addition
of 20 mL of 10 v/v% TEOS (in cyclohexane) to the CTAC-TEA aqueous solution. Post
12 hours, the particle solution was washed with DI water twice by centrifugation. Then
additional surfactant removal and storage preparation was performed as was done for the
MSNP HP.
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Figure S1: MSNP Volume Calculations.
Volume calculations used for determining the volume of the different MSNP and the
number of MSNP per milligram of particle. These volume calculations were also used to
determine the approximate number of MSNP in different concentrations used in the
experiments and for the fluorescence calibration curve to further determine the relative
fluorescence unit per MSNP.
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MSNP Volume calculations
MSNP2, r=37 nm

3.14*(37^2)*133.8

5.75E+5

2 hemispheres volumes for r=37 nm

((2/3)*3.14*(37^3))*2

2.12E+5

h=133.8 nm

Total volume Rod (37 nm by 133.8 nm)

7.87E+5

MSNP2, r=53 nm

3.14*(53^2)*243.5

2.15E+6

2 hemispheres volumes for r=53 nm

((2/3)*3.14*(53^3))*2

6.23E+5

h= 243.5 nm

Total volume Rod (53nm by 243.5 nm)

2.77E+6

Total volume average of Rod, MSNP2

1.78E+6

(4/3)*3.14*(57.5^3)

7.96E+5

Total Volume of Sphere, MSNP0

7.96E+5

(4/3)*3.14*(61.9^3)

9.91E+5

Total Volume of Sphere, MSNP EISA

9.91E+5

(4/3)*3.14*(47.5^3)

4.49E+5

Total Volume of Sphere, MSNP LP

4.49E+5

V= (3 x sqrt(3))/2) x ((42.9)^2) x 86.3

4.13E+5

MSNP0, r=57.5

MSNP EISA, r=61.9

MSNP LP, r=47.5

MSNP HP, a = 42.9 nm and h = 86.3 nm

Total Volume of a Right hexagonal prism,
MSNP HP
4.13E+5

Table S1: MSNP Volume Used for Determining the Number of MSNP per Milligram
of Particle.
The dimensions of the MSNP for the volume calculations were determined by analysis of
the TEM images of the MSNP. These volume calculations were used to determine how
many MSNP were in 1 milligram of MSNP and in the different concentrations used in the
fluorescence calibration curve to determine the relative fluorescence unit per MSNP.
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Calculation for #MSNP in 1 mg of particles

Calculation example for # of MSNP2
in 1 µg and molarity of 1 µg

#MSNP = v/V = 1E+18 nm^3/Total Volume of
MSNP (V)

MSNP2,µ grams

#MSNP2

1E+18 nm^3/Total Volume V of MSNP2

1

5.62E+8

5.62E+11

3

1.69E+9

1E+18 nm^3/Total Volume V of MSNP0

10

5.62E+9

1.26E+12

30

1.69E+10

1E+18 nm^3/Total Volume V of MSNP EISA

100

5.62E+10

1.01E+12

300

1.69E+11

1000

5.62E+11

1E+18 nm^3/Total Volume V of MSNP LP
2.23E+12

#MSNP2 in 1 µg =
5.62E+11 # MSNP2/mg x 1 mg/1000 µg
equals 5.62E+08 # MSNP2/µg

1E+18 nm^3/Total Volume V of MSNP HP
2.42E+12

1µg of MSNP2 in 100 µl = 0.009 nM of
MSNP2
5.62E+08 #MSNP2/(6.023x10^23) = 9.33E-16
Moles of MSNP2
9.33E-16 Moles MSNP2/(10^-4 L) = 9.33E-12
Molar of MSNP2
9.33E-12 Molar of MSNP2 x 10^9 nanomolar
= 0.009 nM of MSNP2

Table S2: Table of the Volume Calculations Used for Determining the Number of
MSNP per Milligram of Particle and Calculation Example for Determining the
Molarity of MSNP.
These volume calculations were based on the dimensions of the particles calculated by
analysis of TEM images of the MSNP. These volume calculations were used to determine
the number of MSNP in a given mass of MSNP and further calculations were done to
determine the molarity of the MSNP at different concentrations. These volume calculations
were used to determine the number of MSNP at the different concentrations used in
experiments and for the fluorescence calibration curve to assess the relative fluorescence
intensity (unit) per MSNP.
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Figure S2: Fluorescence Intensity Value of Dylight 488 Labeled MSNP.
Fluorescence plate reading was used to obtain the Relative Fluorescence Intensity per mass
for the Dylight 488 MSNP used in the biofunctionalization and inhibition cellular uptake
studies. Dylight 488, FL 1 intensity values were collected at 0.03 µg/µL, 0.1 µg/µl and 0.3
µg/µL of MSNP2, MSNP0 and MSNP EISA using a Wallac 1420-040 Victor 3V multilabel fluorescence plate reader at the UNM Shared Flow Cytometry and High Throughput
Screening Resource Center. The approximate relative fluorescence unit (RFU) per particle
was then calculated for the Dylight 488 MSNP by dividing the relative fluorescence
intensity values by the approximate number of MSNP at each concentration and averaging
the RFU values at the different concentrations. The calculations for number of MSNP were
calculated as shown in Supplemental Figure S1 and Supplemental Table S2 and S3.
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A

B
Figure S3A and S3B: Time Dependent Cellular Uptake of Bare MSNP and EGFRTargeted Protocells.
A549 cells were incubated with 20 µg/mL of either Bare MSNP or EGFR-targeted
Protocells in complete medium for 1, 2, 3 or 6 hours at 37°C and 5% CO2, washed 5X with
PBS, trypsinized, fixed with paraformaldehyde, washed 3X with PBS re-suspended in 1
ml of PBS and mean fluorescence intensity on FL1 channel was read using a BD
Biosciences LSR Fortessa flow cytometer at the UNM Shared Flow Cytometry and High
Throughput Screening Resource Center. % Cellular uptake was calculated for the 3
different (A) bare MSNP (top graph) or (B) EGFR-targeted protocell (bottom graph)
sample groups by comparison of the FL1 mean fluorescence intensity (MFI) data of the
sample groups at each time point to the bare rod-shaped MSNP2 MFI as a reference in S3A
and EGFR-targeted MSNP2 as a reference in S3B. MSNP = bare Mesoporous silica
nanoparticles with Dylight 488; EGFR-T = Epidermal Growth Factor Receptor targeted
Protocells with Dylight 488 MSNP cores.
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Formula to Calculate the # of Nanoparticles Internalized per Cell
Relative Fluorescence Intensity of nanoparticles/# of nanoparticles at Relative
Fluorescence Intensity = Relative Fluorescence Unit per Nanoparticle = RFU
Mean Fluorescence Intensity of Nanoparticle uptake per cell = MFI
MFI/RFU = Approximate # of Nanoparticles Internalized per cell
Figure S4: Formulas to Calculate Relative Fluorescence Unit per particle and
Approximate # of Nanoparticles Internalized per Cell.
These are the formulas used to calculate the number of nanoparticles internalized per cell.
The calculations of number of nanoparticles internalized per cell were determined by the
volumetric calculations based on the data in Table 1, Supplemental Figure S1,
Supplemental Table, S1 and S2, and Supplemental Figure S2 as well as the Mean
Fluorescence Intensity from the flow cytometry data presented in Figure 4.
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Figure S5: Approximate number of Nanoparticles Internalized per Cell
Approximate # of nanoparticles (NPs) internalized/cell was calculated here based on
information in Supplemental Figure S4 & the Mean Fluorescence Intensity values from
flow cytometry data, in Figure 6. The statistical significance of a double sided T-test p≤0.05
is representative for the following comparisons: 1) Top Bare MSNP graph: MSNP2 # NPs
internalized/cell to MSNP EISA sample group for $; MSNP0 # NPs internalized/cell to
other MSNP sample groups for *; 2) Bottom EGFR-targeted (EGFR-T) MSNP graph:
MSNP2 # NPs internalized/cell to other MSNP sample groups for *; MSNP0 # NPs
internalized/cell to MSNP EISA sample group for $.
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# of MSNP/mL used in Cell Experiments
Flow Cytometry
MSNP MSNP2
µg/mL #MSNP/mL
20 1.12E+10
Binding Affinity Study
MSNP MSNP2
µg/mL #MSNP/mL

MSNP0
#MSNP/mL

MSNP EISA
#MSNP/mL

2.51E+10

2.02E+10

MSNP0
#MSNP/mL

MSNP EISA
#MSNP/mL

10

5.62E+09

1.26E+10

1.01E+10

30

1.69E+10

3.77E+10

3.03E+10

100

5.62E+10

1.26E+11

1.01E+11

300

1.69E+11

3.77E+11

3.03E+11

1000

5.62E+11

1.26E+12

1.01E+12

3000
1.69E+12
Fluorescence
Microscopy
MSNP
MSNP2
µg/mL #MSNP/mL

3.77E+12

3.03E+12

MSNP0
#MSNP/mL

MSNP EISA
#MSNP/mL

20

1.12E+10

2.51E+10

2.02E+10

50

2.81E+10

6.28E+10

5.05E+10

MSNP0
#MSNP/mL

MSNP EISA
#MSNP/mL

TEM
MSNP
µg/mL

MSNP2
#MSNP/mL

50

2.81E+10

6.28E+10

5.05E+10

150

8.43E+10

1.88E+11

1.51E+11

300

1.69E+11

3.77E+11

3.03E+11

MSNP HP
#MSNP/mL

MSNP LP
#MSNP/mL

3.63E+11

3.34E+11

Table S3: Number of Nanoparticles Used in Cell Experiments.
The number of nanoparticles used in the cell experiments were calculated based on the
volumetric calculations based on the data in Table 1, Supplemental Figure S1,
Supplemental Table, S1, S2 and S3.

106

Inhibitor

Inhibitor function

Free GE 11 peptide

Blocks GE 11
peptide binding site
Inhibits EGFR
Tyrosine Kinase
Activity 44
Inhibits α4β1
Integrin ligand
binding 76
Inhibits clathrin
coated pits 40, 41
Inhibits
macropinocytosis 35
Disrupts
microtubules 36
Inhibits actin
polymerization 36
Extracts cholesterol
from cellular
membrane
Inhibiting
caveolae/lipid rafts
and membrane
ruffling 34, 36
Prevents active
energy requiring
transport 5

PD153035

LDV

Monodansylcadaverine
(dansylcadaverine)
Amiloride
Nocodazole
Cytochalasin D
Methyl-β-cyclodextrin
(MBCD)

4°C

Bare MSNP
(MSNP2-M2;
MSNP0- M0;
MSNP EISA- ME)
M2, -; M0, -; ME, -

EGFR-Targeted
Protocells
(MSNP2-E2;
MSNP0- E0;
MSNP EISA- EE)
E2, ↑; E0, ↑; EE, ↑

M2, -; M0, -; ME, -

E2, -; E0, -; EE, -

M2, -; M0, -; ME, -

E2, -; E0, -; EE, -

M2, -; M0, ↑; ME, -

E2, -; E0, -; EE, -

M2, ↑; M0, ↑; ME, ↑

E2, -; E0, -; EE, -

M2, ↑; M0, ↑; ME, ↑

E2, ↑; E0, ↑; EE, ↑

M2, ↑; M0, ↑; ME, ↑

E2, ↑; E0, ↑; EE, ↑

M2, ↑; M0, ↑; ME, ↑

E2, ↑; E0, ↑; EE, ↑

M2, ↑; M0, ↑; ME, ↑

E2, ↑; E0, ↑; EE, ↑

Table S4: Summary of Inhibitors used with Respective Inhibition Function and
Outcome on Bare MSNP and EGFR-targeted Protocells Cellular Uptake.
The inhibitors are listed on the left with their function to the right of them. The symbol –
represents no significant change on nanoparticle uptake and the ↑ symbol represents a
significant change in nanoparticle uptake with the inhibition.
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Figure S6: Confocal fluorescence microscopy study to investigate A549 cellular
morphology upon inhibition
Confocal fluorescence microscopy study to investigate A549 cellular morphology upon
inhibition. (B) Inhibition of cellular uptake was performed by A549 cell media 2 hour pretreatment and co-treatment with the following: Amiloride (amil): interferes in
macropinocytosis by inhibiting Na+/H+ exchange; Cytochalasin D (cytoD): inhibits Factin polymerization (cytoskeleton); or Methyl-β-cyclodextrin (MBCD): cholesteroldepletion reagent (caveolae/lipid rafts). The A549 cells were incubated with inhibitors and
Dylight 488 labeled MSNP2 at 20 µg/mL in complete media for 2 hours at 37°C and 5%
CO2. Z-stack images of the fixed cell samples were taken for the different sample groups
on a Leica TCS SP8 confocal microscope with a 63X oil immersion objective at the
University of New Mexico’s Fluorescence Microscopy Shared Resource Facility and a
representative mid-slice of each group is shown above. Stains are as follows: Phalloidin
555 – red stain – f-actin; Dapi 405 – blue stain – nucleus; Dylight 488 - green – MSNP2.
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Figure S7: Binding Curves of EGFR-Targeted Protocells.
Log of apparent binding affinity (Kd) values of high peptide EGFR-targeted protocells with
MSNP0, MSNP2 and MSNP EISA cores. The protocells were incubated with different
concentrations of protocell (10, 30, 100, 300, 1000 and 3000 µgrams/mL of complete
media) on A549 and MRC9 cells on ice for 1 hour, then gently washed with ice-cold PBS
washes 5X, and the FL1 (Dylight 488 in silica) was measured for each well of cells covered
with a 100 µliters of ice cold PBS. Measurements were taken using a Wallac 1420-040
Victor 3V multilabel plate reader in the UNM Shared Flow Cytometry and High
Throughput Screening Resource Center, n=2, error bars represent the standard error of
measurement. The A549 and MRC9 cells were both treated; the MRC9 cells used as a
negative control did not show any marked change in FL between the treated versus nontreated cells.
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Nanoparticle
Binding
At Cell
Plasma
Membrane

A Bare MSNP2

B EGFR-targeted MSNP2

Figure S8A and S8B: Additional TEM ultrastructural analysis of bare MSNP2 and
EGFR-targeted MSNP2 protocell penetration at the plasma membrane
TEM images of A549 cell monolayers after 3 hour incubation with 50 µg/mL media of
Bare rod MSNP2 at 37°C and 5% CO2. Note: we observe the bare MSNP2 rods in all
orientations so they appear from circular to rod shaped. Cells are stained with Osmium
Tetroxide and Uranyl Acetate and Reynold’s lead citrate. Scale bars = 100 nM
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Table 2. Physicochemical Characterization of additional MSNP
samples
MSNP LP
MSNP HP
aspect ratio
1
1~1.2
pore diameter (nm)
9
2.8
surface area (m2/g)
741
942
TEM size, nm
95±6.5
99±8/86.25±6
size in H2O, nm/(PDI)
130±2.6/0.06 120±1.3/0.11
size in RPMI, nm/(PDI)
951±56/0.5
1298±54/0.43
size in CRPMI, nm/(PDI)
138±1/0.02
140±1.3/0.06
zeta-potential (mV) in
H2O
-32.2±1.6
-28.4±2.65
CRPMI
-10.25±0.34
-11.6±0.76

Table S5: Physiochemical Characterization of Additional MSNP
Zeta potential and DLS measurements were taken of MSNP aminated with dye at a dilute
concentration of ~125 µg of MSNP/mL in water (pH=7) or in complete RPMI with 10%
FBS (pH=7.4), CRPMI, using a Zetasizer Nano (Malvern Instruments Ltd.,
Worcestershire, UK), n=3. The MSNP were dispersed by sonication of the stock solutions
in ethanol for 15 s before being aliquoted, centrifuged at 14,000 g for 10 minutes with 5
subsequent water washes and centrifugation at 14,000 g for 10 minutes and resuspension
to give a concentration of 1 mg/mL followed by sonication for 15 s before use. The MSNP
surface were then coated with FBS, by mixing the MSNP in water with 5% FBS before
addition to either water (pH=7), RPMI or CRPMI and sonication for 15 s. The DLS were
measured for each MSNP coated with FBS and read in water (pH=7), RPMI and complete
RPMI with 10% FBS. The pore sizes of the samples determined from analyses of the
desorption branches of the respective nitrogen sorption isotherms was approximately 9 nm
diameter for MSNP LP and 2.8 nm for MSNP HP. The Brunauer-Emmett-Teller (BET)
surface areas of MSNP LP and MSNP HP samples were 741 and 942 m2/g, respectively.
The TEM size was measured using ImageJ software, n≥20 particles. Note the low
polydispersity index (PDI) for both the MSNP HP and MSNP LP in water and CRPMI
indicating very little aggregation and a narrow size range. Both the bare dyed MSNP HP
and MSNP LP have a less negative zeta potential in CRPMI compared to water which can
be related to the increase adsorption of proteins available in the CRPMI.
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MSNP HP (Hexagonal prism shape)

MSNP LP (Spherical shape)

Figure S9: Physiochemical Characterization of additional monodispersed MSNP.
Transmission Electron Microscopy (TEM) of MSNP exhibiting different pore structure and
shape. The top, middle and bottom pair of images are of the following, respectively:
hexagonal prism MSNP HP with the aspect ratio = ~1.0-1.2, dimensions ≈ 99 nm/86.25,
uniform pore size = 2.8 nm spherical MSNP LP with aspect ratio = 1.0, uniform pore size
= 9 nm, the diameter ≈ 95 nm. Note the more uniform size of the bare MSNP. Scale bars
are left to right, 100 nm and 50 nm.
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